CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 4-hydroxynon-2-enal
Accession: CHEBI:32585
browse the term
Definition: An enal consisting of non-2-ene having an oxo group at the 1-position and a hydroxy group at the 4-position.
Synonyms: related_synonym: 4-HNE; 4-Hydroxy-2,3-nonenal; 4-Hydroxy-2-nonenal; 4-Hydroxynonenal; Formula=C9H16O2; HNE; InChI=1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3; InChIKey=JVJFIQYAHPMBBX-UHFFFAOYSA-N; SMILES=[H]C(=CC=O)C(O)CCCCC
xref: CAS:29343-52-0; LINCS:LSM-4344
xref_mesh: MESH:C027576
xref: Wikipedia:4-Hydroxynonenal
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ABCA1 mRNA
CTD
PMID:19191707
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcc1
ATP binding cassette subfamily C member 1
affects binding increases expression multiple interactions
ISO
4-hydroxy-2-nonenal binds to ABCC1 protein 4-hydroxy-2-nonenal results in increased expression of ABCC1 mRNA [GSTM1 protein co-treated with ABCC1 protein] results in increased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:15672542 PMID:19191707 PMID:21925487
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
affects export multiple interactions
EXP ISO
ABCC2 protein affects the export of 4-hydroxy-2-nonenal metabolite 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]
CTD
PMID:12623073 PMID:19326901
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Acta1
actin, alpha 1, skeletal muscle
affects binding
EXP
4-hydroxy-2-nonenal binds to ACTA1 protein
CTD
PMID:15886073
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Actb
actin, beta
affects binding
ISO
ACTB protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actn1
actinin, alpha 1
affects binding
ISO
ACTN1 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Actn4
actinin alpha 4
affects binding
ISO
ACTN4 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ADH7 mRNA
CTD
PMID:19191707
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adi1
acireductone dioxygenase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ADI1 mRNA
CTD
PMID:19191707
NCBI chr 6:45,306,885...45,313,847
Ensembl chr 6:45,306,841...45,313,842
G
Adora1
adenosine A1 receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ADORA1 mRNA
CTD
PMID:12419474
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
G
Adora2b
adenosine A2B receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ADORA2B mRNA
CTD
PMID:19191707
NCBI chr10:46,940,394...46,956,772
Ensembl chr10:46,940,384...46,956,772
G
Adrb2
adrenoceptor beta 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ADRB2 mRNA
CTD
PMID:19191707
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Ago2
argonaute RISC catalytic component 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AGO2 mRNA
CTD
PMID:19191707
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
G
Ago3
argonaute RISC catalytic component 3
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AGO3 mRNA 4-hydroxy-2-nonenal results in increased expression of AGO3 mRNA
CTD
PMID:19191707
NCBI chr 5:138,632,367...138,714,230
Ensembl chr 5:138,639,569...138,714,230
G
Agrn
agrin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AGRN mRNA
CTD
PMID:19191707
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
G
Agt
angiotensinogen
affects binding multiple interactions
ISO
4-hydroxy-2-nonenal binds to AGT protein modified form; AGT protein modified form binds to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal binds to and results in increased lipidation of AGT protein modified form; [AGT protein modified form results in increased chemical synthesis of Lipid Peroxides] which results in increased abundance of 4-hydroxy-2-nonenal; [Ascorbic Acid co-treated with Copper Sulfate] promotes the reaction [AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]]; AGT protein modified form results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]; Losartan inhibits the reaction [[AGT protein modified form co-treated with Ascorbic Acid co-treated with Copper Sulfate] results in increased chemical synthesis of [4-hydroxy-2-nonenal binds to AGT protein modified form]]
CTD
PMID:20977208 PMID:26111765 PMID:31144504
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Ahsa2
activator of HSP90 ATPase homolog 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of AHSA2 mRNA
CTD
PMID:19191707
NCBI chr14:97,476,304...97,485,725
Ensembl chr14:97,476,817...97,485,657
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of AIFM1 mRNA
CTD
PMID:19191707
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Akna
AT-hook transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AKNA mRNA
CTD
PMID:19191707
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
G
Akr1a1
aldo-keto reductase family 1 member A1
increases reduction increases expression
ISO
AKR1A1 protein results in increased reduction of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of AKR1A1 mRNA
CTD
PMID:10510318 PMID:19191707
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1b1
aldo-keto reductase family 1 member B1
affects reduction increases reduction
ISO
AKR1B1 protein affects the reduction of 4-hydroxy-2-nonenal AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal; AKR1B1 protein results in increased reduction of 4-hydroxy-2-nonenal metabolite
CTD
PMID:9890881 PMID:10510318 PMID:11306073 PMID:21329684
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases reduction multiple interactions increases metabolic processing
ISO
AKR1B10 protein results in increased reduction of 4-hydroxy-2-nonenal Oleanolic Acid inhibits the reaction [AKR1B10 protein results in increased metabolism of 4-hydroxy-2-nonenal]
CTD
PMID:19013440 PMID:21329684 PMID:27417252
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c3
aldo-keto reductase family 1, member C3
increases expression increases response to substance multiple interactions
ISO
4-hydroxy-2-nonenal results in increased expression of AKR1C3 mRNA; 4-hydroxy-2-nonenal results in increased expression of AKR1C3 protein AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal 7-hydroxycoumarin inhibits the reaction [AKR1C3 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal]
CTD
PMID:22964423 PMID:30849339
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Akr7a2
aldo-keto reductase family 7, member A2
decreases response to substance affects response to substance increases response to substance multiple interactions increases expression
ISO
AKR7A2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal AKR7A2 protein affects the susceptibility to 4-hydroxy-2-nonenal AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal 7-hydroxycoumarin affects the reaction [AKR7A2 mutant form results in increased susceptibility to 4-hydroxy-2-nonenal]; AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] 4-hydroxy-2-nonenal results in increased expression of AKR7A2 mRNA; 4-hydroxy-2-nonenal results in increased expression of AKR7A2 protein
CTD
PMID:22001351 PMID:22964423 PMID:30849339
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Akt1
AKT serine/threonine kinase 1
affects response to substance multiple interactions increases activity decreases phosphorylation
EXP ISO
AKT1 protein affects the susceptibility to 4-hydroxy-2-nonenal AKT1 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2 protein] 4-hydroxy-2-nonenal results in increased activity of AKT1 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of AKT1 protein
CTD
PMID:18805481 PMID:23845594 PMID:24825450
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
multiple interactions
ISO
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of RB1 protein modified form; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of TNF protein; [ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene]
CTD
PMID:33007382
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases metabolic processing multiple interactions increases oxidation
ISO
ALDH1A1 protein results in increased metabolism of 4-hydroxy-2-nonenal [APC protein mutant form results in increased expression of ALDH1A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH1A1 protein results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:21256123 PMID:21967605 PMID:22339434
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh2
aldehyde dehydrogenase 2 family member
multiple interactions increases oxidation
ISO
[APC protein mutant form results in increased expression of ALDH2 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH2 protein results in increased oxidation of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal binds to and results in decreased activity of ALDH2 protein; ALDH2 protein inhibits the reaction [Rotenone results in increased abundance of 4-hydroxy-2-nonenal]
CTD
PMID:21967605 PMID:22339434 PMID:25263579
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
decreases response to substance affects metabolic processing affects response to substance increases metabolic processing multiple interactions increases oxidation
ISO EXP
ALDH3A1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal ALDH3A1 protein affects the metabolism of 4-hydroxy-2-nonenal ALDH3A1 protein affects the susceptibility to 4-hydroxy-2-nonenal ALDH3A1 protein results in increased metabolism of 4-hydroxy-2-nonenal [APC protein mutant form results in increased expression of ALDH3A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal ALDH3A1 protein results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:11018474 PMID:11306050 PMID:15905174 PMID:21256123 PMID:21967605 PMID:22339434 More...
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
affects binding decreases response to substance
ISO
4-hydroxy-2-nonenal binds to ALDH3B1 protein ALDH3B1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:20699116
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ALDH6A1 mRNA
CTD
PMID:19191707
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
increases metabolic processing decreases response to substance
ISO
ALDH7A1 protein results in increased metabolism of 4-hydroxy-2-nonenal ALDH7A1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:21338592
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
G
Aldoa
aldolase, fructose-bisphosphate A
affects binding
ISO
ALDOA protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldoc
aldolase, fructose-bisphosphate C
multiple interactions
ISO
Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to ALDOA protein]
CTD
PMID:20889679
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alox5
arachidonate 5-lipoxygenase
multiple interactions
ISO
ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]
CTD
PMID:19837106
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ALOX5AP mRNA
CTD
PMID:19191707
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Alpk1
alpha-kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ALPK1 mRNA
CTD
PMID:19191707
NCBI chr 2:216,126,939...216,247,180
Ensembl chr 2:216,128,825...216,247,157
G
Als2
alsin Rho guanine nucleotide exchange factor ALS2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ALS2 mRNA
CTD
PMID:19191707
NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737
G
Amph
amphiphysin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AMPH mRNA
CTD
PMID:12419474
NCBI chr17:45,739,385...45,982,905
Ensembl chr17:45,739,395...45,983,315
G
Anln
anillin, actin binding protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ANLN mRNA
CTD
PMID:19191707
NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ANP32A mRNA
CTD
PMID:19191707
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
G
Aoah
acyloxyacyl hydrolase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AOAH mRNA
CTD
PMID:19191707
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
G
Aox1
aldehyde oxidase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of AOX1 mRNA
CTD
PMID:19191707
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
G
Ap1s3
adaptor related protein complex 1 subunit sigma 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AP1S3 mRNA
CTD
PMID:19191707
NCBI chr 9:80,950,402...81,009,889
Ensembl chr 9:80,950,715...81,009,798
G
Apc
APC regulator of WNT signaling pathway
decreases expression multiple interactions affects response to substance affects oxidation
ISO
4-hydroxy-2-nonenal results in decreased expression of APC mRNA [APC protein affects the oxidation of 4-hydroxy-2-nonenal] which affects the abundance of 4-hydroxynonenoic acid; [APC protein mutant form results in increased expression of ALDH1A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of ALDH2 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of ALDH3A1 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of GSTA4 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal; [APC protein mutant form results in increased expression of SLC7A11 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal APC protein affects the susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:12419474 PMID:21967605
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of APEX1 mRNA
CTD
PMID:19191707
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apoa1
apolipoprotein A1
affects binding
ISO
4-hydroxy-2-nonenal binds to APOA1 protein
CTD
PMID:18778096
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Apod
apolipoprotein D
decreases abundance
ISO
APOD protein results in decreased abundance of 4-hydroxy-2-nonenal
CTD
PMID:28182653
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
G
App
amyloid beta precursor protein
decreases expression multiple interactions
ISO
4-hydroxy-2-nonenal results in decreased expression of APP mRNA [[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; [APP protein modified form inhibits the reaction [[Copper co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide]] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; Deferoxamine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; Trientine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]
CTD
PMID:12419474 PMID:17964426
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arhgap11a
Rho GTPase activating protein 11A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ARHGAP11A mRNA
CTD
PMID:19191707
NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
G
Arhgap22
Rho GTPase activating protein 22
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ARHGAP22 mRNA
CTD
PMID:19191707
NCBI chr16:8,473,806...8,631,552
Ensembl chr16:8,476,306...8,631,548
G
Arhgap27
Rho GTPase activating protein 27
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ARHGAP27 mRNA
CTD
PMID:19191707
NCBI chr10:88,280,470...88,313,225
Ensembl chr10:88,280,455...88,313,185
G
Arhgap5
Rho GTPase activating protein 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ARHGAP5 mRNA
CTD
PMID:12419474
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ARHGDIA mRNA
CTD
PMID:12419474
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
G
Arhgef3
Rho guanine nucleotide exchange factor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ARHGEF3 mRNA
CTD
PMID:19191707
NCBI chr16:2,301,573...2,581,951
Ensembl chr16:2,300,138...2,581,945
G
Arid5a
AT-rich interaction domain 5A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ARID5A mRNA
CTD
PMID:19191707
NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597
G
Arrdc3
arrestin domain containing 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ARRDC3 mRNA
CTD
PMID:19191707
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ASF1B mRNA 4-hydroxy-2-nonenal results in increased expression of ASF1B mRNA
CTD
PMID:19191707
NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
G
Aspm
assembly factor for spindle microtubules
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ASPM mRNA
CTD
PMID:19191707
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
G
Atad5
ATPase family, AAA domain containing 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ATAD5 mRNA
CTD
PMID:19191707
NCBI chr10:65,070,682...65,118,489
Ensembl chr10:65,070,689...65,117,845
G
Atf3
activating transcription factor 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ATF3 protein
CTD
PMID:19041636
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atf4
activating transcription factor 4
increases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in increased expression of ATF4 mRNA; 4-hydroxy-2-nonenal results in increased expression of ATF4 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF4 protein]
CTD
PMID:24291486
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atf6
activating transcription factor 6
increases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]
CTD
PMID:24291486
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atg5
autophagy related 5
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ATG5 mRNA
CTD
PMID:35550146
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atg7
autophagy related 7
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ATG7 mRNA
CTD
PMID:35550146
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Atm
ATM serine/threonine kinase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ATM mRNA
CTD
PMID:19191707
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp1b3
ATPase Na+/K+ transporting subunit beta 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ATP1B3 mRNA
CTD
PMID:12419474
NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:96,910,309...96,941,598
G
Atp5f1a
ATP synthase F1 subunit alpha
affects binding
ISO
4-hydroxy-2-nonenal binds to ATP5F1A protein
CTD
PMID:19374891
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
G
Atp6v1a
ATPase H+ transporting V1 subunit A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ATP6V1A mRNA
CTD
PMID:19191707
NCBI chr11:56,561,444...56,614,694
Ensembl chr11:56,560,974...56,614,694
G
Atr
ATR serine/threonine kinase
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ATR mRNA 4-hydroxy-2-nonenal results in increased expression of ATR mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
G
Avil
advillin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AVIL mRNA
CTD
PMID:19191707
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
G
B2m
beta-2 microglobulin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of B2M mRNA
CTD
PMID:19191707
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BABAM2 mRNA
CTD
PMID:19191707
NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951
G
Bad
BCL2-associated agonist of cell death
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BAD mRNA 4-hydroxy-2-nonenal results in increased expression of BAD protein
CTD
PMID:12419474 PMID:24825450
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Batf2
basic leucine zipper ATF-like transcription factor 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BATF2 mRNA
CTD
PMID:19191707
NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression increases expression
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of BAX mRNA 4-hydroxy-2-nonenal results in increased expression of BAX protein
CTD
PMID:12419474 PMID:15607904 PMID:21187080 PMID:24825450
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
multiple interactions increases expression
EXP
4-phenylbutylamine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of BBC3 mRNA]
CTD
PMID:24291486
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bbx
BBX high mobility group box domain containing
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BBX mRNA
CTD
PMID:19191707
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
G
Bcar3
BCAR3 adaptor protein, NSP family member
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BCAR3 mRNA
CTD
PMID:19191707
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bcl2a1
BCL2-related protein A1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BCL2A1B mRNA
CTD
PMID:19191707
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BCL2L11 mRNA
CTD
PMID:19191707
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bcl3
BCL3, transcription coactivator
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BCL3 mRNA
CTD
PMID:19191707
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
G
Bcl6
BCL6, transcription repressor
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BCL6 mRNA
CTD
PMID:19191707
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
G
Bdnf
brain-derived neurotrophic factor
decreases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA]
CTD
PMID:16337876
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
Bgn
biglycan
multiple interactions
ISO
[[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal
CTD
PMID:35234341
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
G
Bhlhe40
basic helix-loop-helix family, member e40
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BHLHE40 mRNA
CTD
PMID:19191707
NCBI chr 4:141,618,453...141,624,154
Ensembl chr 4:141,618,476...141,624,774
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BHLHE41 mRNA
CTD
PMID:19191707
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
G
Bid
BH3 interacting domain death agonist
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BID mRNA
CTD
PMID:19191707
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc5
baculoviral IAP repeat-containing 5
increases expression decreases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BIRC5 mRNA 4-hydroxy-2-nonenal results in decreased expression of BIRC5 mRNA
CTD
PMID:19191707
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Blm
BLM RecQ like helicase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BLM mRNA
CTD
PMID:19191707
NCBI chr 1:134,409,832...134,496,073
Ensembl chr 1:134,409,857...134,484,312
G
Blvrb
biliverdin reductase B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BLVRB mRNA
CTD
PMID:19191707
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BMP1 mRNA
CTD
PMID:12419474
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Bnip3
BCL2 interacting protein 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BNIP3 mRNA
CTD
PMID:12419474
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BRAF mRNA
CTD
PMID:12419474
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BUB1 mRNA
CTD
PMID:19191707
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
G
Bub1b
BUB1 mitotic checkpoint serine/threonine kinase B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of BUB1B mRNA
CTD
PMID:19191707
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
G
Bzw1
basic leucine zipper and W2 domains 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of BZW1 mRNA
CTD
PMID:19191707
NCBI chr 9:59,930,672...59,944,468
Ensembl chr 9:59,930,744...59,944,430
G
C5ar1
complement C5a receptor 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of C5AR1 mRNA
CTD
PMID:19191707
NCBI chr 1:76,948,622...76,959,826
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CACNA1A mRNA
CTD
PMID:19191707
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Cadps
calcium dependent secretion activator
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CADPS mRNA
CTD
PMID:19191707
NCBI chr15:12,289,803...12,742,786
Ensembl chr15:12,290,262...12,742,779
G
Calca
calcitonin-related polypeptide alpha
increases secretion
EXP
4-hydroxy-2-nonenal results in increased secretion of CALCA protein
CTD
PMID:17684094
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
G
Calcoco1
calcium binding and coiled coil domain 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CALCOCO1 mRNA
CTD
PMID:19191707
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
G
Calr3
calreticulin 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CALR3 mRNA
CTD
PMID:19191707
NCBI chr16:17,396,064...17,423,166
Ensembl chr16:17,396,247...17,423,015
G
Camk1d
calcium/calmodulin-dependent protein kinase ID
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CAMK1D mRNA
CTD
PMID:19191707
NCBI chr17:72,581,899...72,982,704
Ensembl chr17:72,581,979...72,980,556
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
affects binding
ISO
CAP1 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
G
Capn2
calpain 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CAPN2 mRNA
CTD
PMID:12419474
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Capns1
calpain, small subunit 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CAPNS1 mRNA
CTD
PMID:12419474
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
G
Capzb
capping actin protein of muscle Z-line subunit beta
affects binding
ISO
CAPZB protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
G
Car12
carbonic anhydrase 12
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CAR12 mRNA
CTD
PMID:19191707
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Car2
carbonic anhydrase 2
affects binding
ISO
CA2 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Carhsp1
calcium regulated heat stable protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CARHSP1 mRNA
CTD
PMID:19191707
NCBI chr10:6,946,036...6,960,556
Ensembl chr10:6,946,959...7,020,019
G
Cask
calcium/calmodulin dependent serine protein kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CASK mRNA
CTD
PMID:12419474
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp1
caspase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CASP1 mRNA
CTD
PMID:19191707
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO EXP
4-hydroxy-2-nonenal results in increased cleavage of and results in increased activity of CASP3 protein; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein] Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP3 protein] 4-hydroxy-2-nonenal results in increased cleavage of CASP3 protein
CTD
PMID:11488593 PMID:16322078 PMID:16337876 PMID:17263905 PMID:19326901 PMID:20114059 PMID:21187080 PMID:24291486 PMID:24825450 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CASP4 mRNA
CTD
PMID:19191707
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp7
caspase 7
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CASP7 mRNA
CTD
PMID:19191707
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CASP8 mRNA
CTD
PMID:12419474
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in increased activity of CASP9 protein pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of CASP9 protein]
CTD
PMID:16322078 PMID:17263905 PMID:21187080 PMID:24825450
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CAT mRNA
CTD
PMID:19191707 PMID:24423726
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cblb
Cbl proto-oncogene B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CBLB mRNA
CTD
PMID:12419474
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
Ccl17
C-C motif chemokine ligand 17
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL17 mRNA 4-hydroxy-2-nonenal results in increased expression of CCL17 mRNA
CTD
PMID:19191707
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL2 mRNA
CTD
PMID:19191707
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl22
C-C motif chemokine ligand 22
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL22 mRNA
CTD
PMID:19191707
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccl3
C-C motif chemokine ligand 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL3 mRNA
CTD
PMID:12419474
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL4 mRNA
CTD
PMID:19191707
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions decreases expression
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CCL5 protein] 4-hydroxy-2-nonenal results in decreased expression of CCL5 mRNA
CTD
PMID:19191707 PMID:19627980
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccl7
C-C motif chemokine ligand 7
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL7 mRNA
CTD
PMID:19191707
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
Ccl9
C-C motif chemokine ligand 9
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCL6 mRNA
CTD
PMID:19191707
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccna2
cyclin A2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNA2 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNB1 mRNA
CTD
PMID:19191707
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
multiple interactions increases expression
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CCND1] 4-hydroxy-2-nonenal results in increased expression of CCND1; 4-hydroxy-2-nonenal results in increased expression of CCND1 mRNA
CTD
PMID:16328008 PMID:19191707
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCND2 protein
CTD
PMID:15607904
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccnd3
cyclin D3
multiple interactions
ISO
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein]
CTD
PMID:33007382
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccnf
cyclin F
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNF mRNA
CTD
PMID:19191707
NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
G
Ccng1
cyclin G1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CCNG1 mRNA
CTD
PMID:19191707
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccng2
cyclin G2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNG2 mRNA
CTD
PMID:19191707
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
G
Ccnk
cyclin K
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNK mRNA
CTD
PMID:12419474
NCBI chr 6:127,090,115...127,113,195
Ensembl chr 6:127,090,569...127,113,191
G
Ccnt1
cyclin T1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCNT1 mRNA
CTD
PMID:12419474
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
G
Ccr1
C-C motif chemokine receptor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CCR1 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 8:123,556,286...123,561,841
G
Cd14
CD14 molecule
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CD14 mRNA
CTD
PMID:19191707
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd300a
Cd300a molecule
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CD300A mRNA
CTD
PMID:19191707
NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674
G
Cd300lb
CD300 molecule-like family member b
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CD300LB mRNA
CTD
PMID:19191707
NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790
G
Cd300lf
Cd300 molecule-like family member F
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD300LF mRNA
CTD
PMID:19191707
NCBI chr10:100,359,942...100,376,130
Ensembl chr10:100,359,943...100,376,041
G
Cd36
CD36 molecule
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CD36 mRNA
CTD
PMID:19191707
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cd40
CD40 molecule
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD40 mRNA
CTD
PMID:19191707
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD44 mRNA
CTD
PMID:19191707
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd47
Cd47 molecule
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD47 mRNA
CTD
PMID:12419474
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
G
Cd83
CD83 molecule
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD83 mRNA
CTD
PMID:19191707
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cd86
CD86 molecule
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CD86 mRNA
CTD
PMID:19191707
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
Cdc20
cell division cycle 20
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDC20 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc25a
cell division cycle 25A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDC25A mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdc25c
cell division cycle 25C
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDC25C mRNA
CTD
PMID:19191707
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdca2
cell division cycle associated 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDCA2 mRNA
CTD
PMID:19191707
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
G
Cdh1
cadherin 1
multiple interactions
ISO
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in decreased expression of CDH1 protein
CTD
PMID:34503147
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDH2 mRNA
CTD
PMID:12419474
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cdh3
cadherin 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDH3 mRNA
CTD
PMID:12419474
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdk2
cyclin dependent kinase 2
multiple interactions
ISO
4-hydroxy-2-nonenal binds to and results in increased alkylation of and results in decreased activity of CDK2 protein
CTD
PMID:26910110
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk6
cyclin-dependent kinase 6
increases expression multiple interactions
ISO
4-hydroxy-2-nonenal results in increased expression of CDK6 mRNA [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein]
CTD
PMID:19191707 PMID:33007382
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdk9
cyclin-dependent kinase 9
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDK9 mRNA
CTD
PMID:12419474
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CDKN1A protein
CTD
PMID:15607904
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDKN1C mRNA
CTD
PMID:12419474
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CDKN2D mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA
CTD
PMID:19191707
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Cenpa
centromere protein A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CENPA mRNA
CTD
PMID:19191707
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
G
Cep290
centrosomal protein 290
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CEP290 mRNA
CTD
PMID:19191707
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
G
Ces1d
carboxylesterase 1D
decreases activity
ISO
4-hydroxy-2-nonenal results in decreased activity of CES1 protein
CTD
PMID:21878322
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Ces2h
carboxylesterase 2H
increases activity
ISO
4-hydroxy-2-nonenal results in increased activity of CES2 protein
CTD
PMID:21878322
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Cfb
complement factor B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CFB mRNA
CTD
PMID:19191707
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
G
Cfl1
cofilin 1
affects binding
ISO
CFL1 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
G
Chek1
checkpoint kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CHEK1 mRNA
CTD
PMID:19191707
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
G
Chml
CHM like Rab escort protein
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CHML mRNA
CTD
PMID:19191707
NCBI chr13:87,609,647...87,619,868
Ensembl chr13:87,589,298...87,619,862
G
Cilk1
ciliogenesis associated kinase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CILK1 mRNA
CTD
PMID:19191707
NCBI chr 8:78,984,075...79,042,695
Ensembl chr 8:78,984,258...79,042,691
G
Cish
cytokine inducible SH2-containing protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CISH mRNA
CTD
PMID:19191707
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CKS1B mRNA
CTD
PMID:19191707
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CKS2 mRNA
CTD
PMID:19191707
NCBI chr17:13,570,611...13,575,770
G
Cldn11
claudin 11
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CLDN11 mRNA
CTD
PMID:19191707
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
Clec12a
C-type lectin domain family 12, member A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CLEC12A mRNA
CTD
PMID:19191707
NCBI chr 4:162,798,125...162,816,757
Ensembl chr 4:162,798,125...162,816,753
G
Clec4a
C-type lectin domain family 4, member A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CLEC4N mRNA
CTD
PMID:19191707
NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402
G
Clec4d
C-type lectin domain family 4, member D
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CLEC4D mRNA
CTD
PMID:19191707
NCBI chr 4:156,589,591...156,599,279
Ensembl chr 4:156,589,792...156,598,848
G
Clec5a
C-type lectin domain containing 5A
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CLEC5A mRNA 4-hydroxy-2-nonenal results in increased expression of CLEC5A mRNA
CTD
PMID:19191707
NCBI chr 4:69,407,125...69,416,872
Ensembl chr 4:69,407,835...69,416,859
G
Clk3
CDC-like kinase 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CLK3 mRNA
CTD
PMID:12419474
NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:58,152,155...58,168,181
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of COL1A1 mRNA; 4-hydroxy-2-nonenal results in increased expression of COL1A1 protein
CTD
PMID:14672615
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Comt
catechol-O-methyltransferase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of COMT mRNA
CTD
PMID:12419474
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
G
Cp
ceruloplasmin
decreases expression affects abundance
ISO
4-hydroxy-2-nonenal results in decreased expression of CP mRNA CP protein affects the abundance of 4-hydroxy-2-nonenal
CTD
PMID:12572680 PMID:19191707
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpe
carboxypeptidase E
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CPE mRNA
CTD
PMID:12419474
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Creb1
cAMP responsive element binding protein 1
decreases expression increases phosphorylation
ISO
4-hydroxy-2-nonenal results in decreased expression of CREB1 mRNA 4-hydroxy-2-nonenal results in increased phosphorylation of CREB1 protein
CTD
PMID:12419474 PMID:16337876
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Crebbp
CREB binding protein
multiple interactions
EXP
CREBBP protein inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of BDNF mRNA]
CTD
PMID:16337876
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CREG1 mRNA
CTD
PMID:19191707
NCBI chr13:78,019,814...78,032,310
Ensembl chr13:78,019,843...78,032,308
G
Crot
carnitine O-octanoyltransferase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CROT mRNA
CTD
PMID:19191707
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Cry1
cryptochrome circadian regulator 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CRY1 mRNA
CTD
PMID:19191707
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
G
Cry2
cryptochrome circadian regulator 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CRY2 mRNA
CTD
PMID:19191707
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
G
Cryz
crystallin zeta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CRYZ mRNA
CTD
PMID:12419474
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Csf1r
colony stimulating factor 1 receptor
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CSF1R mRNA
CTD
PMID:19191707
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Csf2
colony stimulating factor 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CSF2 mRNA
CTD
PMID:19191707
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf3
colony stimulating factor 3
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CSF3 mRNA 4-hydroxy-2-nonenal results in increased expression of CSF3 mRNA; 4-hydroxy-2-nonenal results in increased expression of CSF3 protein
CTD
PMID:19191707
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Csnk1g2
casein kinase 1, gamma 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CSNK1G2 mRNA
CTD
PMID:12419474
NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052
G
Csrnp1
cysteine and serine rich nuclear protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of AXUD1 mRNA
CTD
PMID:19191707
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Ctnnb1
catenin beta 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA; 4-hydroxy-2-nonenal results in decreased expression of CTNNB1 protein
CTD
PMID:12419474 PMID:24825450
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsd
cathepsin D
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA]
CTD
PMID:35550146
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Ctsl
cathepsin L
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CTSL mRNA
CTD
PMID:12419474
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Cttn
cortactin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CTTN mRNA
CTD
PMID:12419474
NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164
G
Cux1
cut-like homeobox 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CUX1 mRNA
CTD
PMID:12419474
NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein]
CTD
PMID:19627980
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl14
C-X-C motif chemokine ligand 14
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CXCL14 mRNA
CTD
PMID:19191707
NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CXCL1 mRNA
CTD
PMID:19191707
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of CXCR4 mRNA
CTD
PMID:19191707
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cybb
cytochrome b-245 beta chain
increases abundance
ISO
CYBB protein results in increased abundance of 4-hydroxy-2-nonenal
CTD
PMID:19417757
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
ISO EXP
4-hydroxy-2-nonenal affects the localization of CYCS protein pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal affects the localization of CYCS protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal affects the localization of CYCS protein]
CTD
PMID:16322078 PMID:17263905 PMID:21187080
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
ISO
[CYP1A2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP1A2 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:21766881
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CYP1B1 mRNA
CTD
PMID:12419474
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions
ISO
[CYP2B6 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2B6 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2B6 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:21766881
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
[CYP2C29 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2C29 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2C29 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:21766881
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
multiple interactions
ISO
[CYP2J2 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid; [CYP2J2 protein results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; CYP2J2 protein results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal
CTD
PMID:21766881
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
[[CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 1,4-dihydroxy-2-nonene; [CYP3A4 protein co-treated with Oxygen co-treated with NADP] results in increased reduction of and results in increased oxidation of 4-hydroxy-2-nonenal; [CYP3A4 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid
CTD
PMID:21766881
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cysltr1
cysteinyl leukotriene receptor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CYSLTR1 mRNA
CTD
PMID:19191707
NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121
G
Cyth4
cytohesin 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of CYTH4 mRNA
CTD
PMID:19191707
NCBI chr 7:110,152,232...110,176,726
Ensembl chr 7:110,152,272...110,176,741
G
Dap
death-associated protein
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of DAP mRNA
CTD
PMID:19191707
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DAPK1 mRNA
CTD
PMID:12419474
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DBF4 mRNA
CTD
PMID:19191707
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:25,676,634...25,701,066
G
Dcn
decorin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DCN mRNA
CTD
PMID:19191707
NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA; 4-hydroxy-2-nonenal results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of DDIT3 mRNA]
CTD
PMID:24291486
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DDIT4 mRNA
CTD
PMID:19191707
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddr2
discoidin domain receptor tyrosine kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DDR2 mRNA
CTD
PMID:12419474
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Denr
density regulated reinitiation and release factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DENR mRNA
CTD
PMID:19191707
NCBI chr12:32,662,512...32,685,283
Ensembl chr12:32,662,516...32,683,843
G
Dffa
DNA fragmentation factor subunit alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DFFA mRNA
CTD
PMID:12419474
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
G
Dffb
DNA fragmentation factor subunit beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DFFB mRNA
CTD
PMID:12419474
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
G
Dgkh
diacylglycerol kinase, eta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DGKH mRNA
CTD
PMID:19191707
NCBI chr15:53,981,079...54,150,470
Ensembl chr15:53,991,481...54,150,706
G
Dhx58
DEXH-box helicase 58
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DHX58 mRNA
CTD
PMID:19191707
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Dio2
iodothyronine deiodinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DIO2 mRNA
CTD
PMID:19191707
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dlgap5
DLG associated protein 5
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DLGAP5 mRNA 4-hydroxy-2-nonenal results in increased expression of DLGAP5 mRNA
CTD
PMID:19191707
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of DNAJB4 mRNA
CTD
PMID:19191707
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DNAJC3 mRNA
CTD
PMID:12419474
NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181
G
Dnase2
deoxyribonuclease 2, lysosomal
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of DNASE2A mRNA
CTD
PMID:19191707
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DNPH1 mRNA
CTD
PMID:12419474
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
G
Dpysl2
dihydropyrimidinase-like 2
affects binding
ISO
4-hydroxy-2-nonenal binds to DPYSL2 protein
CTD
PMID:19374891
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
G
Drd2
dopamine receptor D2
decreases expression
EXP
4-hydroxy-2-nonenal results in decreased expression of DRD2 protein
CTD
PMID:20570720
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
G
Dst
dystonin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of DST mRNA
CTD
PMID:12419474
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
G
Dynlt3
dynein light chain Tctex-type 3
affects binding
ISO
DYNLT3 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr X:13,327,933...13,337,139
Ensembl chr X:13,327,892...13,337,139
G
E2f1
E2F transcription factor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of E2F1 mRNA
CTD
PMID:12419474
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
E2f2
E2F transcription factor 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of E2F2 mRNA
CTD
PMID:19191707
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
G
E2f8
E2F transcription factor 8
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of E2F8 mRNA
CTD
PMID:19191707
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
G
Echdc3
enoyl CoA hydratase domain containing 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ECHDC3 mRNA
CTD
PMID:19191707
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Edn1
endothelin 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EDN1 mRNA
CTD
PMID:19191707
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
EXP
4-hydroxy-2-nonenal results in decreased expression of EEF2 protein
CTD
PMID:16469450
NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
G
Efna4
ephrin A4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EFNA4 mRNA
CTD
PMID:12419474
NCBI chr 2:174,748,729...174,752,979
Ensembl chr 2:174,748,724...174,752,979
G
Eid3
EP300 interacting inhibitor of differentiation 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of EID3 mRNA
CTD
PMID:19191707
NCBI chr 7:20,860,073...20,861,395
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation
ISO
4-hydroxy-2-nonenal results in increased phosphorylation of EIF2A protein
CTD
PMID:19041636
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EIF2AK2 mRNA
CTD
PMID:19191707
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases phosphorylation
ISO
4-hydroxy-2-nonenal results in increased phosphorylation of EIF2AK3 protein
CTD
PMID:19041636
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
multiple interactions increases phosphorylation
EXP
Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of EIF2S1 protein]
CTD
PMID:24291486
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eif4e
eukaryotic translation initiation factor 4E
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of EIF4E mRNA
CTD
PMID:19191707
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
G
Eif4e2
eukaryotic translation initiation factor 4E family member 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of EIF4E2 mRNA
CTD
PMID:19191707
NCBI chr 9:87,886,126...87,914,470
Ensembl chr 9:87,878,085...87,914,482
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
increases phosphorylation
EXP
4-hydroxy-2-nonenal results in increased phosphorylation of EIF4EBP1 protein
CTD
PMID:9890986
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Eif5a
eukaryotic translation initiation factor 5A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of EIF5A mRNA
CTD
PMID:19191707
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Elk1
ETS transcription factor ELK1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ELK1 mRNA
CTD
PMID:12419474
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
G
Eloc
elongin C
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ELOC mRNA
CTD
PMID:12419474
NCBI chr 5:2,661,527...2,677,893
Ensembl chr 5:2,661,724...2,677,890
G
Elp1
elongator acetyltransferase complex subunit 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ELP1 mRNA
CTD
PMID:12419474
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
G
Eme1
essential meiotic structure-specific endonuclease 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EME1 mRNA
CTD
PMID:19191707
NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435
G
Eno1
enolase 1
affects binding
ISO
4-hydroxy-2-nonenal binds to ENO1 protein
CTD
PMID:19374891
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of EPHX1 mRNA
CTD
PMID:19191707
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Eps15
epidermal growth factor receptor pathway substrate 15
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EPS15 mRNA
CTD
PMID:12419474
NCBI chr 5:124,045,865...124,146,221
Ensembl chr 5:124,045,926...124,146,221
G
Eps8
EGFR pathway substrate 8, signaling adaptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EPS8 mRNA
CTD
PMID:12419474
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
G
Epsti1
epithelial stromal interaction 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EPSTI1 mRNA
CTD
PMID:19191707
NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERBB2 mRNA
CTD
PMID:12419474
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERBB4 mRNA
CTD
PMID:12419474
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERCC1 mRNA
CTD
PMID:19191707
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Ercc2
ERCC excision repair 2, TFIIH core complex helicase subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERCC2 mRNA
CTD
PMID:12419474
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
G
Ercc5
ERCC excision repair 5, endonuclease
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERCC5 mRNA
CTD
PMID:12419474
NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
G
Ercc6l
ERCC excision repair 6 like, spindle assembly checkpoint helicase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERCC6L mRNA
CTD
PMID:19191707
NCBI chr X:67,245,414...67,261,222
Ensembl chr X:67,245,414...67,280,756
G
Ern1
endoplasmic reticulum to nucleus signaling 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ERN1 mRNA
CTD
PMID:19191707
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Espl1
extra spindle pole bodies like 1, separase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ESPL1 mRNA
CTD
PMID:19191707
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
G
Ets1
ETS proto-oncogene 1, transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ETS1 mRNA
CTD
PMID:12419474
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ETS2 mRNA
CTD
PMID:12419474
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ETV3 mRNA
CTD
PMID:12419474
NCBI chr 2:172,965,461...172,980,320
Ensembl chr 2:172,965,588...172,980,314
G
Etv6
ETS variant transcription factor 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ETV6 mRNA
CTD
PMID:12419474
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
G
Ezr
ezrin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of EZR mRNA
CTD
PMID:12419474
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F10
coagulation factor X
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of F10 mRNA
CTD
PMID:19191707
NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of F2R mRNA
CTD
PMID:12419474
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
F3
coagulation factor III, tissue factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of F3 mRNA
CTD
PMID:19191707
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Fancd2
FA complementation group D2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FANCD2 mRNA
CTD
PMID:19191707
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
G
Fastk
Fas-activated serine/threonine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FASTK mRNA
CTD
PMID:12419474
NCBI chr 4:10,732,273...10,736,332
Ensembl chr 4:10,732,256...10,737,430
G
Fbxl17
F-box and leucine-rich repeat protein 17
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FBXL17 mRNA
CTD
PMID:19191707
NCBI chr 9:102,780,573...103,206,978
Ensembl chr 9:102,782,440...103,208,950
G
Fbxl20
F-box and leucine-rich repeat protein 20
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FBXL20 mRNA 4-hydroxy-2-nonenal results in increased expression of FBXL20 mRNA
CTD
PMID:19191707
NCBI chr10:83,080,568...83,143,680
Ensembl chr10:83,086,551...83,144,162
G
Fbxo15
F-box protein 15
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FBXO15 mRNA
CTD
PMID:19191707
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
G
Fbxo22
F-box protein 22
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FBXO22 mRNA
CTD
PMID:19191707
NCBI chr 8:55,579,906...55,595,981
Ensembl chr 8:55,579,891...55,596,148
G
Fbxo30
F-box protein 30
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FBXO30 mRNA
CTD
PMID:19191707
NCBI chr 1:5,655,341...5,671,558
Ensembl chr 1:5,655,339...5,672,441
G
Fbxo31
F-box protein 31
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FBXO31 mRNA
CTD
PMID:19191707
NCBI chr19:49,624,813...49,656,052
Ensembl chr19:49,627,686...49,656,010
G
Fbxo39
F-box protein 39
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FBXO39 mRNA
CTD
PMID:19191707
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
G
Fbxo5
F-box protein 5
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FBXO5 mRNA 4-hydroxy-2-nonenal results in increased expression of FBXO5 mRNA
CTD
PMID:19191707
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
G
Fcgr1a
Fc gamma receptor 1A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FCGR1 mRNA; 4-hydroxy-2-nonenal results in decreased expression of FCGR1A mRNA
CTD
PMID:19191707
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fcgr2b
Fc gamma receptor 2B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FCGR2B mRNA
CTD
PMID:19191707
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
G
Fech
ferrochelatase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FECH mRNA
CTD
PMID:12419474
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
G
Fem1c
fem-1 homolog C
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FEM1C mRNA
CTD
PMID:19191707
NCBI chr18:39,232,900...39,258,692
Ensembl chr18:39,232,900...39,258,692
G
Fen1
flap structure-specific endonuclease 1
increases expression decreases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FEN1 mRNA 4-hydroxy-2-nonenal results in decreased expression of FEN1 mRNA
CTD
PMID:19191707
NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003
G
Fgfr1
Fibroblast growth factor receptor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FGFR1 mRNA
CTD
PMID:12419474
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
G
Fgr
FGR proto-oncogene, Src family tyrosine kinase
increases expression decreases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FGR mRNA 4-hydroxy-2-nonenal results in decreased expression of FGR mRNA
CTD
PMID:19191707
NCBI chr 5:145,189,814...145,219,571
Ensembl chr 5:145,189,841...145,217,326
G
Fkbp14
FKBP prolyl isomerase 14
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FKBP14 mRNA
CTD
PMID:19191707
NCBI chr 4:83,705,531...83,721,515
Ensembl chr 4:83,705,652...83,721,528
G
Fkbpl
FKBP prolyl isomerase like
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of FKBPL mRNA
CTD
PMID:19191707
NCBI chr20:4,099,845...4,101,315
Ensembl chr20:4,099,806...4,101,368
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of FOS mRNA 4-hydroxy-2-nonenal results in decreased expression of FOS protein resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of FOS protein] 4-hydroxy-2-nonenal promotes the reaction [FOS protein binds to GGT1 promoter]
CTD
PMID:12419474 PMID:16195535 PMID:16322078
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
4-hydroxy-2-nonenal promotes the reaction [FOSB protein binds to GGT1 promoter]
CTD
PMID:16195535
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
multiple interactions
EXP
4-hydroxy-2-nonenal promotes the reaction [FOSL1 protein binds to GGT1 promoter]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]]
CTD
PMID:9890986 PMID:16195535
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
multiple interactions
EXP
4-hydroxy-2-nonenal promotes the reaction [FOSL2 protein binds to GGT1 promoter]
CTD
PMID:16195535
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxm1
forkhead box M1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FOXM1 mRNA
CTD
PMID:19191707
NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
G
Foxo3
forkhead box O3
multiple interactions
ISO
FOXO3 protein inhibits the reaction [SRT1720 inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal]]
CTD
PMID:24633890
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Foxp1
forkhead box P1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FOXP1 mRNA
CTD
PMID:19191707
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
G
Fpr3
formyl peptide receptor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FPR3 mRNA
CTD
PMID:19191707
NCBI chr 1:58,884,427...58,893,472
Ensembl chr 1:58,845,118...58,893,467
G
Fubp1
far upstream element binding protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of FUBP1 mRNA
CTD
PMID:12419474
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
G
Fxn
frataxin
multiple interactions
ISO
4-hydroxy-2-nonenal affects the reaction [Ethanol affects the expression of FXN protein]
CTD
PMID:33017621
NCBI chr 1:221,874,007...221,897,543
Ensembl chr 1:221,872,420...221,897,540
G
G6pd
glucose-6-phosphate dehydrogenase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of G6PDX mRNA
CTD
PMID:19191707
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gabarapl1
GABA type A receptor associated protein like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GABARAPL1 mRNA
CTD
PMID:19191707
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GADD45A mRNA]
CTD
PMID:19191707 PMID:24291486
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gak
cyclin G associated kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GAK mRNA
CTD
PMID:12419474
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
[Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein]] which results in decreased activity of GAPDH protein; [Hydroxyurea results in increased abundance of Free Radicals] promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein]; Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GAPDH protein]
CTD
PMID:20889679 PMID:23696560
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gata3
GATA binding protein 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GATA3 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gatad2b
GATA zinc finger domain containing 2B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GATAD2B mRNA
CTD
PMID:19191707
NCBI chr 2:175,748,594...175,829,837
Ensembl chr 2:175,749,433...175,825,542
G
Gatb
glutamyl-tRNA amidotransferase subunit B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GATB mRNA
CTD
PMID:19191707
NCBI chr 2:170,930,547...171,017,133
Ensembl chr 2:170,930,542...171,016,695
G
Gbp1
guanylate binding protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GBP1 mRNA
CTD
PMID:19191707
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gbp4
guanylate binding protein 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GBP3 mRNA
CTD
PMID:19191707
NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879
G
Gbp5
guanylate binding protein 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GBP5 mRNA
CTD
PMID:19191707
NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in increased expression of GCLC mRNA 4-hydroxy-2-nonenal results in increased expression of GCLC protein NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA]
CTD
PMID:19191707 PMID:24291486
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GCLM mRNA
CTD
PMID:19191707
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gen1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GEN1 mRNA
CTD
PMID:19191707
NCBI chr 6:33,947,599...33,978,461
Ensembl chr 6:33,948,206...33,978,401
G
Ggnbp1
gametogenetin binding protein 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GGNBP1 mRNA
CTD
PMID:19191707
NCBI chr20:5,109,849...5,116,185
Ensembl chr20:5,099,311...5,116,183
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GGT1 mRNA]; 4-hydroxy-2-nonenal promotes the reaction [FOS protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSL1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [FOSL2 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [JUN protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [JUNB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [NFE2L1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal promotes the reaction [NFE2L2 protein binds to GGT1 promoter]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GGT1 mRNA]
CTD
PMID:16195535
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gna13
G protein subunit alpha 13
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GNA13 mRNA
CTD
PMID:19191707
NCBI chr10:94,337,939...94,370,774
Ensembl chr10:94,337,725...94,370,774
G
Gnaq
G protein subunit alpha q
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GNAQ mRNA
CTD
PMID:19191707
NCBI chr 1:213,425,631...213,671,947
Ensembl chr 1:213,424,465...213,667,672
G
Gnas
GNAS complex locus
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GNAS mRNA
CTD
PMID:12419474
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnat3
G protein subunit alpha transducin 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GNAT3 mRNA
CTD
PMID:19191707
NCBI chr 4:17,162,500...17,212,283
Ensembl chr 4:17,162,490...17,212,283
G
Gnb1
G protein subunit beta 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GNB1 mRNA
CTD
PMID:12419474
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Gnb2
G protein subunit beta 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GNB2 mRNA
CTD
PMID:12419474
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
G
Got2
glutamic-oxaloacetic transaminase 2
multiple interactions
ISO
Hydroxyurea promotes the reaction [4-hydroxy-2-nonenal binds to GOT2 protein]
CTD
PMID:20889679
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
G
Gpr183
G protein-coupled receptor 183
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GPR183 mRNA
CTD
PMID:19191707
NCBI chr15:99,037,764...99,050,550
Ensembl chr15:99,036,367...99,050,559
G
Gpx1
glutathione peroxidase 1
increases abundance
ISO
GPX1 gene mutant form results in increased abundance of 4-hydroxy-2-nonenal
CTD
PMID:24296279
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GPX2 mRNA
CTD
PMID:12419474
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
G
Gsk3b
glycogen synthase kinase 3 beta
decreases expression decreases phosphorylation
ISO
4-hydroxy-2-nonenal results in decreased expression of GSK3B mRNA 4-hydroxy-2-nonenal results in decreased phosphorylation of GSK3B protein
CTD
PMID:12419474 PMID:24825450
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GSN mRNA
CTD
PMID:19191707
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gsr
glutathione-disulfide reductase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GSR mRNA
CTD
PMID:19191707
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Gss
glutathione synthetase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GSS mRNA
CTD
PMID:19191707
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
Gsta1
glutathione S-transferase alpha 1
decreases response to substance increases expression affects metabolic processing multiple interactions
ISO EXP
GSTA1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA GSTA1 protein affects the metabolism of 4-hydroxy-2-nonenal analog [GSTA1 protein binds to GSTA3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog
CTD
PMID:9799558 PMID:11256969 PMID:15829614
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gsta3
glutathione S-transferase alpha 3
multiple interactions
EXP
[GSTA1 protein binds to GSTA3 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog
CTD
PMID:11256969
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gsta4
glutathione S-transferase alpha 4
multiple interactions affects metabolic processing increases expression
ISO EXP
GSTA4 protein binds to and affects the metabolism of 4-hydroxy-2-nonenal GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal; GSTA4 protein affects the metabolism of 4-hydroxy-2-nonenal analog 4-hydroxy-2-nonenal results in increased expression of GSTA4 mRNA; 4-hydroxy-2-nonenal results in increased expression of GSTA4 protein
CTD
PMID:2619714 PMID:7878679 PMID:8142470 PMID:8203886 PMID:9461507 PMID:9799558 PMID:10514034 PMID:11162605 PMID:11256969 PMID:11302754 PMID:11488593 PMID:12600725 PMID:15829614 PMID:16005854 More...
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gsta5
glutathione S-transferase alpha 5
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of GSTA1 mRNA
CTD
PMID:19191707
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstm1
glutathione S-transferase mu 1
multiple interactions affects metabolic processing
ISO EXP
[GSTM1 protein co-treated with 4-hydroxy-2-nonenal] results in decreased abundance of Glutathione; [GSTM1 protein co-treated with ABCC1 protein] results in increased susceptibility to 4-hydroxy-2-nonenal GSTM1 protein affects the metabolism of 4-hydroxy-2-nonenal analog [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog
CTD
PMID:11256969 PMID:21925487
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstm2
glutathione S-transferase mu 2
decreases response to substance multiple interactions affects metabolic processing
ISO EXP
GSTM2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog GSTM2 protein affects the metabolism of 4-hydroxy-2-nonenal analog
CTD
PMID:11256969 PMID:15829614
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
multiple interactions decreases response to substance increases expression affects binding decreases expression
ISO EXP
4-hydroxy-2-nonenal binds to and results in decreased activity of GSTP1 protein GSTP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of GSTP1 protein 4-hydroxy-2-nonenal analog binds to GSTP1 4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein Glutathione inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of GSTP1 protein] 4-hydroxy-2-nonenal results in increased expression of GSTP1 mRNA
CTD
PMID:9463521 PMID:11600134 PMID:15829614 PMID:18232660 PMID:19191707 PMID:20570720 More...
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gtf2b
general transcription factor IIB
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of GTF2B mRNA
CTD
PMID:12419474
NCBI chr 2:231,767,317...231,785,626
Ensembl chr 2:231,767,238...231,785,651
G
H2ax
H2A.X variant histone
multiple interactions increases expression increases phosphorylation
ISO
POLH protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; POLK protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; POLL protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; REV1 protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]; REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] 4-hydroxy-2-nonenal results in increased expression of H2AX protein [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in increased expression of H2AX protein
CTD
PMID:22331492 PMID:34503147
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
decreases activity
ISO
4-hydroxy-2-nonenal results in decreased activity of H6PD protein
CTD
PMID:20211231
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
Haspin
histone H3 associated protein kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HASPIN mRNA
CTD
PMID:19191707
NCBI chr10:57,747,731...57,750,518
Ensembl chr10:57,747,573...57,750,512
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HBEGF mRNA
CTD
PMID:12419474
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hbp1
HMG-box transcription factor 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HBP1 mRNA
CTD
PMID:19191707
NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787
G
Hck
HCK proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HCK mRNA
CTD
PMID:19191707
NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693
G
Hdc
histidine decarboxylase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HDC mRNA
CTD
PMID:19191707
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hells
helicase, lymphoid specific
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HELLS mRNA
CTD
PMID:19191707
NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
G
Herc3
HECT and RLD domain containing E3 ubiquitin protein ligase 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HERC3 mRNA
CTD
PMID:19191707
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
G
Herc4
HECT and RLD domain containing E3 ubiquitin protein ligase 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HERC5 mRNA
CTD
PMID:19191707
NCBI chr20:25,329,972...25,404,657
Ensembl chr20:25,330,280...25,404,657
G
Hgf
hepatocyte growth factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HGF mRNA
CTD
PMID:12419474
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hint1
histidine triad nucleotide binding protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HINT1 mRNA
CTD
PMID:12419474
NCBI chr10:38,989,516...38,993,259
Ensembl chr 4:92,100,973...92,101,568
G
Hivep2
HIVEP zinc finger 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HIVEP2 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 1:8,358,205...8,555,993
Ensembl chr 1:8,359,289...8,555,993
G
Hivep3
HIVEP zinc finger 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HIVEP3 mRNA
CTD
PMID:19191707
NCBI chr 5:133,325,327...133,727,797
Ensembl chr 5:133,658,052...133,727,795
G
Hlx
H2.0-like homeobox
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HLX mRNA
CTD
PMID:19191707
NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750
G
Hmga1
high mobility group AT-hook 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HMGA1 mRNA
CTD
PMID:12419474
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HMGA2 mRNA
CTD
PMID:19191707
NCBI chr 7:55,877,145...55,998,813
Ensembl chr 7:55,880,112...55,994,784
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal analog results in increased expression of HMOX1; 4-hydroxy-2-nonenal results in increased expression of HMOX1; 4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA; 4-hydroxy-2-nonenal results in increased expression of HMOX1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; methyl-beta-cyclodextrin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein] 4-phenylbutylamine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA] 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; wortmannin inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]
CTD
PMID:18232660 PMID:19191707 PMID:20638469 PMID:23845594 PMID:24291486 PMID:24423726 PMID:30849339 More...
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf4a
hepatocyte nuclear factor 4, alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HNF4A mRNA
CTD
PMID:12419474
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HPRT1 mRNA
CTD
PMID:19191707
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HSD17B11 mRNA
CTD
PMID:19191707
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
affects binding
EXP ISO
4-hydroxy-2-nonenal binds to HSP90AA1 protein 4-hydroxy-2-nonenal analog binds to HSP90AA1
CTD
PMID:18232660 PMID:21749116
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
affects binding
EXP
4-hydroxy-2-nonenal binds to HSP90AB1 protein
CTD
PMID:21749116
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
affects binding
ISO
4-hydroxy-2-nonenal analog binds to HSPA1A
CTD
PMID:18232660
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HSPA1B mRNA
CTD
PMID:19191707
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
affects binding
ISO
4-hydroxy-2-nonenal analog binds to HSPA1L
CTD
PMID:18232660
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HSPA2 mRNA
CTD
PMID:12419474
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa4l
heat shock protein family A (Hsp70) member 4 like
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HSPA4L mRNA
CTD
PMID:19191707
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
G
Hspa5
heat shock protein family A (Hsp70) member 5
affects binding multiple interactions increases expression
ISO EXP
4-hydroxy-2-nonenal analog binds to HSPA5 Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA] 4-hydroxy-2-nonenal results in increased expression of HSPA5 mRNA; 4-hydroxy-2-nonenal results in increased expression of HSPA5 protein
CTD
PMID:18232660 PMID:24291486
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa9
heat shock protein family A (Hsp70) member 9
affects binding
ISO
4-hydroxy-2-nonenal analog binds to HSPA9
CTD
PMID:18232660
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
G
Hspd1
heat shock protein family D (Hsp60) member 1
affects binding
ISO
4-hydroxy-2-nonenal analog binds to HSPD1
CTD
PMID:18232660
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HSPH1 mRNA
CTD
PMID:19191707
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of HTATIP2 mRNA
CTD
PMID:19191707
NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
G
Hus1
HUS1 checkpoint clamp component
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of HUS1 mRNA
CTD
PMID:19191707
NCBI chr14:83,688,702...83,703,466
Ensembl chr14:83,688,708...83,703,442
G
Icam1
intercellular adhesion molecule 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ICAM1 mRNA
CTD
PMID:19191707
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id1
inhibitor of DNA binding 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ID1 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of IDH1 mRNA
CTD
PMID:19191707
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
G
Ier3
immediate early response 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IER3 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
G
Ifi44l
interferon-induced protein 44-like
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFI44L mRNA
CTD
PMID:19191707
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFIH1 mRNA
CTD
PMID:19191707
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFIT2 mRNA
CTD
PMID:19191707
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFIT3 mRNA
CTD
PMID:19191707
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm2
interferon induced transmembrane protein 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFITM2 mRNA
CTD
PMID:19191707
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
G
Ifnb1
interferon beta 1
multiple interactions
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 protein]
CTD
PMID:19627980
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
multiple interactions
ISO
[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein; [Trichloroethylene co-treated with 4-hydroxy-2-nonenal analog] results in increased expression of IFNG protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein]
CTD
PMID:18267128 PMID:33007382
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of IGF1 mRNA
CTD
PMID:19191707
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IGF1R mRNA
CTD
PMID:12419474
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Ikbke
inhibitor of nuclear factor kappa B kinase subunit epsilon
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of IKBKE mRNA
CTD
PMID:19191707
NCBI chr13:42,712,154...42,738,470
Ensembl chr13:42,712,159...42,737,143
G
Ikzf1
IKAROS family zinc finger 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IKZF1 mRNA
CTD
PMID:19191707
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
G
Il10
interleukin 10
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL10 mRNA
CTD
PMID:19191707
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il10ra
interleukin 10 receptor subunit alpha
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of IL10RA mRNA
CTD
PMID:19191707
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
G
Il12rb1
interleukin 12 receptor subunit beta 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL12RB1 mRNA
CTD
PMID:12419474
NCBI chr16:18,620,228...18,633,207
Ensembl chr16:18,620,770...18,632,769
G
Il13ra1
interleukin 13 receptor subunit alpha 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL13RA1 mRNA
CTD
PMID:19191707
NCBI chr X:115,348,822...115,408,682
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il17a
interleukin 17A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL17A mRNA
CTD
PMID:12419474
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
Il18
interleukin 18
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL18 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il18rap
interleukin 18 receptor accessory protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL18RAP mRNA
CTD
PMID:19191707
NCBI chr 9:42,768,112...42,800,964
Ensembl chr 9:42,768,220...42,800,959
G
Il1a
interleukin 1 alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL1A mRNA
CTD
PMID:19191707
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL1B mRNA
CTD
PMID:19191707
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rl1
interleukin 1 receptor-like 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL1RL1 mRNA
CTD
PMID:19191707
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
G
Il1rn
interleukin 1 receptor antagonist
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL1RN mRNA
CTD
PMID:19191707
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il2
interleukin 2
multiple interactions
ISO
[Trichloroethylene co-treated with 4-hydroxy-2-nonenal analog] results in increased expression of IL2 protein
CTD
PMID:18267128
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
G
Il27
interleukin 27
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL27 mRNA
CTD
PMID:19191707
NCBI chr 1:181,173,108...181,178,720
Ensembl chr 1:181,173,372...181,178,582
G
Il3
interleukin 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL3 mRNA
CTD
PMID:12419474
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
G
Il36a
interleukin 36, alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL36A mRNA
CTD
PMID:19191707
NCBI chr 3:6,996,851...7,001,400
Ensembl chr 3:6,996,851...7,001,400
G
Il4r
interleukin 4 receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL4RA mRNA
CTD
PMID:19191707
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
decreases expression multiple interactions
ISO
4-hydroxy-2-nonenal results in decreased expression of IL6 mRNA [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein]
CTD
PMID:19191707 PMID:33007382
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6r
interleukin 6 receptor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL6R mRNA
CTD
PMID:12419474
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL6ST mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Il7r
interleukin 7 receptor
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL7R mRNA 4-hydroxy-2-nonenal results in increased expression of IL7R mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
Il9
interleukin 9
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IL9 mRNA
CTD
PMID:12419474
NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895
G
Impact
impact RWD domain protein
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IMPACT mRNA 4-hydroxy-2-nonenal results in increased expression of IMPACT mRNA
CTD
PMID:19191707
NCBI chr18:4,108,872...4,147,571
Ensembl chr18:4,108,853...4,147,569
G
Inppl1
inositol polyphosphate phosphatase-like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of INPPL1 mRNA
CTD
PMID:19191707
NCBI chr 1:156,183,043...156,197,500
Ensembl chr 1:156,183,059...156,197,500
G
Insig2
insulin induced gene 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of INSIG2 mRNA
CTD
PMID:19191707
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Irak3
interleukin-1 receptor-associated kinase 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IRAK3 mRNA
CTD
PMID:19191707
NCBI chr 7:55,653,949...55,714,371
Ensembl chr 7:55,653,962...55,713,121
G
Irf3
interferon regulatory factor 3
multiple interactions
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of IRF3 protein]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]
CTD
PMID:19627980
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
G
Irf7
interferon regulatory factor 7
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IRF7 mRNA
CTD
PMID:19191707
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irf8
interferon regulatory factor 8
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IRF8 mRNA
CTD
PMID:19191707
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Irgm
immunity-related GTPase M
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IRGM mRNA
CTD
PMID:19191707
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ISG15 mRNA
CTD
PMID:19191707
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ISG20 mRNA
CTD
PMID:19191707
NCBI chr 1:132,829,303...132,837,027
Ensembl chr 1:132,815,123...132,837,027
G
Itga5
integrin subunit alpha 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGA5 mRNA
CTD
PMID:12419474
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
G
Itga6
integrin subunit alpha 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGA6 mRNA
CTD
PMID:12419474
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
G
Itga7
integrin subunit alpha 7
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGA7 mRNA
CTD
PMID:12419474
NCBI chr 7:1,360,125...1,388,886
Ensembl chr 7:1,359,940...1,388,450
G
Itgal
integrin subunit alpha L
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGAL mRNA
CTD
PMID:19191707
NCBI chr 1:181,918,183...181,955,735
Ensembl chr 1:181,918,183...181,955,732
G
Itgam
integrin subunit alpha M
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGAM mRNA
CTD
PMID:19191707
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Itgb6
integrin subunit beta 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITGB6 mRNA
CTD
PMID:12419474
NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
G
Itsn1
intersectin 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ITSN1 mRNA
CTD
PMID:12419474
NCBI chr11:30,978,590...31,160,645
Ensembl chr11:30,978,590...31,160,645
G
Jak2
Janus kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of JAK2 mRNA
CTD
PMID:19191707
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Jdp2
Jun dimerization protein 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of JDP2 mRNA
CTD
PMID:19191707
NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions increases phosphorylation affects response to substance
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of JUN mRNA 4-hydroxy-2-nonenal promotes the reaction [JUN protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of JUN protein; 4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]]; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein]; Quercetin inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of JUN protein] JUN protein affects the susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]; 4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein; pyrazolanthrone inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUN protein]]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of and results in increased phosphorylation of JUN protein]
CTD
PMID:9890986 PMID:11488593 PMID:12419474 PMID:16195535 PMID:16322078 PMID:16337876 PMID:17263905 More...
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
EXP
4-hydroxy-2-nonenal promotes the reaction [JUNB protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]]
CTD
PMID:9890986 PMID:16195535
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of JUND mRNA 4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]; FOSL1 protein affects the reaction [4-hydroxy-2-nonenal results in increased activity of [JUN protein binds to JUND protein binds to JUNB protein]]
CTD
PMID:9890986 PMID:12419474
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kat8
lysine acetyltransferase 8
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of KAT8 mRNA
CTD
PMID:19191707
NCBI chr 1:182,524,355...182,536,638
Ensembl chr 1:182,515,327...182,536,633
G
Kdm6b
lysine demethylase 6B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KDM6B mRNA
CTD
PMID:19191707
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
G
Kif11
kinesin family member 11
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KIF11 mRNA
CTD
PMID:19191707
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
G
Kif20b
kinesin family member 20B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KIF20B mRNA
CTD
PMID:19191707
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
G
Kitlg
KIT ligand
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of KITL mRNA
CTD
PMID:19191707
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Klf7
KLF transcription factor 7
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KLF7 mRNA
CTD
PMID:19191707
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Klhl6
kelch-like family member 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KLHL6 mRNA
CTD
PMID:19191707
NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of KPNA2 mRNA
CTD
PMID:19191707
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Lamp1
lysosomal-associated membrane protein 1
increases expression multiple interactions
ISO
4-hydroxy-2-nonenal results in increased expression of LAMP1 mRNA; 4-hydroxy-2-nonenal results in increased expression of LAMP1 protein Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]
CTD
PMID:35550146
NCBI chr16:76,355,982...76,380,700
Ensembl chr16:76,355,984...76,381,883
G
Lat
linker for activation of T cells
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LAT mRNA
CTD
PMID:12419474
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LCAT mRNA
CTD
PMID:12419474
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LCK mRNA
CTD
PMID:12419474
NCBI chr 5:141,888,318...141,916,945
Ensembl chr 5:141,888,326...141,903,794
G
Lif
LIF, interleukin 6 family cytokine
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LIF mRNA
CTD
PMID:19191707
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
G
Lipa
lipase A, lysosomal acid type
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of LIPA mRNA
CTD
PMID:19191707
NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:232,024,356...232,057,633
G
Lipg
lipase G, endothelial type
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LIPG mRNA
CTD
PMID:19191707
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lpar1
lysophosphatidic acid receptor 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of LPAR1 mRNA
CTD
PMID:19191707
NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
G
Lpin1
lipin 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of LPIN1 mRNA
CTD
PMID:19191707
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lrrc59
leucine rich repeat containing 59
affects binding
ISO
LRRC59 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
G
Lrrfip2
LRR binding FLII interacting protein 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of LRRFIP2 mRNA
CTD
PMID:19191707
NCBI chr 8:111,091,453...111,193,947
Ensembl chr 8:111,091,503...111,193,255
G
Ltb
lymphotoxin beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LTB mRNA
CTD
PMID:19191707
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
G
Ly6e
lymphocyte antigen 6 family member E
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LY6E mRNA
CTD
PMID:19191707
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Ly96
lymphocyte antigen 96
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of LY96 mRNA
CTD
PMID:19191707
NCBI chr 5:2,582,233...2,612,357
Ensembl chr 5:2,582,254...2,612,386
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of LYN mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Maf1
MAF1 homolog, negative regulator of RNA polymerase III
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MAF1 mRNA
CTD
PMID:19191707
NCBI chr 7:108,075,173...108,078,252
Ensembl chr 7:108,075,189...108,078,249
G
Mafb
MAF bZIP transcription factor B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MAFB mRNA
CTD
PMID:19191707
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Mafg
MAF bZIP transcription factor G
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MAFG mRNA
CTD
PMID:19191707
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA
CTD
PMID:19191707
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MAP2K5 mRNA
CTD
PMID:12419474
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
G
Map3k20
mitogen-activated protein kinase kinase kinase 20
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MAP3K20 mRNA
CTD
PMID:19191707
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
G
Mapk1
mitogen activated protein kinase 1
decreases activity multiple interactions increases phosphorylation
ISO EXP
4-hydroxy-2-nonenal results in decreased activity of MAPK1 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; 4-hydroxy-2-nonenal results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]; 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK1 protein 4-hydroxy-2-nonenal results in increased activity of and results in increased phosphorylation of MAPK1 protein
CTD
PMID:16322078 PMID:17263905 PMID:23845594 PMID:24291486 PMID:24423726
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions increases expression
ISO
4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein; Acetylcysteine inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; Hydrogen Peroxide promotes the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein] 4-hydroxy-2-nonenal results in increased expression of MAPK14 mRNA 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK14 protein]
CTD
PMID:12684028 PMID:16322078 PMID:19191707
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
decreases activity multiple interactions increases phosphorylation
ISO EXP
4-hydroxy-2-nonenal results in decreased activity of MAPK3 protein 4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; 4-hydroxy-2-nonenal results in increased activity of [MAPK1 protein co-treated with MAPK3 protein]; 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK3 protein 4-hydroxy-2-nonenal results in increased activity of and results in increased phosphorylation of MAPK3 protein
CTD
PMID:16322078 PMID:17263905 PMID:23845594 PMID:24291486 PMID:24423726
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases activity increases phosphorylation affects response to substance multiple interactions
ISO
4-hydroxy-2-nonenal results in increased activity of MAPK8 protein 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK8 protein MAPK8 protein affects the susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein; GSTA4 protein inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of MAPK8 protein]; Resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein] 4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein; Hydrogen Peroxide promotes the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of and results in increased activity of MAPK8 protein]
CTD
PMID:11488593 PMID:12684028 PMID:15064094 PMID:16322078 PMID:17263905 PMID:24825450 More...
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
4-hydroxy-2-nonenal results in increased phosphorylation of MAPK9 protein
CTD
PMID:24825450
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Marcksl1
MARCKS-like 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MARCKSL1 mRNA
CTD
PMID:12419474
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Mark3
microtubule affinity regulating kinase 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MARK3 mRNA
CTD
PMID:12419474
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MCM4 mRNA
CTD
PMID:12419474
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm6
minichromosome maintenance complex component 6
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MCM6 mRNA
CTD
PMID:19191707
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
G
Metap1d
methionyl aminopeptidase type 1D (mitochondrial)
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of METAP1D mRNA
CTD
PMID:19191707
NCBI chr 3:56,279,471...56,354,518
Ensembl chr 3:56,279,493...56,351,981
G
Mettl14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
multiple interactions
ISO
METTL14 protein promotes the reaction [Doxorubicin results in increased abundance of 4-hydroxy-2-nonenal]
CTD
PMID:34648132
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MITF mRNA
CTD
PMID:23489423
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA
CTD
PMID:19191707
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mknk1
MAPK interacting serine/threonine kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MKNK1 mRNA
CTD
PMID:19191707
NCBI chr 5:129,318,128...129,357,641
Ensembl chr 5:129,318,170...129,357,639
G
Mlh1
mutL homolog 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MLH1 mRNA
CTD
PMID:12419474
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
G
Mmp1
matrix metallopeptidase 1
increases activity increases expression
ISO
4-hydroxy-2-nonenal results in increased activity of MMP1 protein 4-hydroxy-2-nonenal results in increased expression of MMP1 mRNA
CTD
PMID:14672615
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp2
matrix metallopeptidase 2
increases activity increases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in increased activity of MMP2 protein 4-hydroxy-2-nonenal results in increased expression of MMP2 mRNA 1-((1-O-octadecyl-2-O-methylglycero)phospho)-3-deoxy-myo-inositol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2]; 4-hydroxy-2-nonenal results in increased expression of and results in increased secretion of and results in increased activity of MMP2 protein; AKT1 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of MMP2 protein]
CTD
PMID:14672615 PMID:18805481
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
decreases expression increases activity multiple interactions increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MMP9 mRNA 4-hydroxy-2-nonenal results in increased activity of MMP9 protein ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; MK-886 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein]; U 75302 inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] 4-hydroxy-2-nonenal results in increased expression of MMP9 mRNA; 4-hydroxy-2-nonenal results in increased expression of MMP9 protein
CTD
PMID:19191707 PMID:19837106
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mnda
myeloid cell nuclear differentiation antigen
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of IFI16 mRNA; 4-hydroxy-2-nonenal results in decreased expression of IFI204 mRNA 4-hydroxy-2-nonenal results in decreased expression of MNDA mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr13:86,017,888...86,035,556
Ensembl chr13:86,017,892...86,034,201
G
Mocos
molybdenum cofactor sulfurase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MOCOS mRNA
CTD
PMID:19191707
NCBI chr18:15,931,659...15,977,415
Ensembl chr18:15,931,654...15,977,187
G
Mov10
Mov10 RNA helicase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MOV10 mRNA
CTD
PMID:19191707
NCBI chr 2:192,292,041...192,315,142
Ensembl chr 2:192,293,470...192,315,083
G
Ms4a6a
membrane spanning 4-domains A6A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MS4A6C mRNA
CTD
PMID:19191707
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
G
Msh5
mutS homolog 5
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MSH5 mRNA
CTD
PMID:19191707
NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
G
Mt1
metallothionein 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MT1 mRNA
CTD
PMID:20979157
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MT2 mRNA
CTD
PMID:19191707
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfs
methenyltetrahydrofolate synthetase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MTHFS mRNA
CTD
PMID:19191707
NCBI chr 8:89,729,498...89,801,998
Ensembl chr 8:89,729,508...89,799,089
G
Mtmr10
myotubularin related protein 10
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MTMR10 mRNA
CTD
PMID:19191707
NCBI chr 1:117,859,355...117,910,839
Ensembl chr 1:117,859,267...117,910,849
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MTOR mRNA
CTD
PMID:12419474
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mtss1
MTSS I-BAR domain containing 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MTSS1 mRNA
CTD
PMID:19191707
NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
G
Mutyh
mutY DNA glycosylase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of MUTYH mRNA
CTD
PMID:19191707
NCBI chr 5:130,274,034...130,286,149
Ensembl chr 5:130,274,122...130,286,146
G
Mx1
MX dynamin like GTPase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MX1 mRNA; 4-hydroxy-2-nonenal results in decreased expression of MX2 mRNA
CTD
PMID:19191707
NCBI chr11:36,799,659...36,825,209
Ensembl chr11:36,799,660...36,823,507
G
Mxd1
max dimerization protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MXD1 mRNA
CTD
PMID:19191707
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Mybl2
MYB proto-oncogene like 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MYBL2 mRNA
CTD
PMID:12419474
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MYC mRNA
CTD
PMID:12419474
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Mylk
myosin light chain kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of MYLK mRNA
CTD
PMID:12419474
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
G
Nab2
Ngfi-A binding protein 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NAB2 mRNA
CTD
PMID:19191707
NCBI chr 7:63,497,589...63,504,105
Ensembl chr 7:63,497,589...63,503,989
G
Napb
NSF attachment protein beta
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NAPB mRNA
CTD
PMID:19191707
NCBI chr 3:136,132,248...136,179,280
Ensembl chr 3:136,133,428...136,179,345
G
Nbn
nibrin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NBN mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
G
Nck1
NCK adaptor protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NCK1 mRNA
CTD
PMID:12419474
NCBI chr 8:101,018,610...101,079,237
Ensembl chr 8:101,018,702...101,079,300
G
Ndc80
NDC80 kinetochore complex component
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NDC80 mRNA
CTD
PMID:19191707
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
G
Nectin1
nectin cell adhesion molecule 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NECTIN1 mRNA
CTD
PMID:12419474
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
G
Neil3
nei-like DNA glycosylase 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NEIL3 mRNA
CTD
PMID:19191707
NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
G
Nek2
NIMA-related kinase 2
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NEK2 mRNA 4-hydroxy-2-nonenal results in increased expression of NEK2 mRNA
CTD
PMID:19191707
NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
G
Nek3
NIMA-related kinase 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NEK3 mRNA
CTD
PMID:19191707
NCBI chr16:69,867,020...69,892,477
Ensembl chr16:69,867,047...69,892,508
G
Nek6
NIMA-related kinase 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NEK6 mRNA
CTD
PMID:19191707
NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990
G
Neo1
neogenin 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NEO1 mRNA
CTD
PMID:12419474
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
G
Neu1
neuraminidase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NEU1 mRNA
CTD
PMID:35550146
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NF2 mRNA
CTD
PMID:12419474
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
G
Nfam1
NFAT activating protein with ITAM motif 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NFAM1 mRNA
CTD
PMID:19191707
NCBI chr 7:114,139,318...114,175,395
Ensembl chr 7:114,139,345...114,175,442
G
Nfatc1
nuclear factor of activated T-cells 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NFATC1 mRNA
CTD
PMID:12419474
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l1
NFE2 like bZIP transcription factor 1
decreases expression multiple interactions increases expression
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of NFE2L1 mRNA 4-hydroxy-2-nonenal promotes the reaction [NFE2L1 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of NFE2L1 protein 4-hydroxy-2-nonenal results in increased expression of NFE2L1 protein
CTD
PMID:12419474 PMID:16195535
NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity multiple interactions affects response to substance affects localization increases expression
ISO EXP
4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein AKR7A2 protein affects the reaction [NFE2L2 protein affects the susceptibility to 4-hydroxy-2-nonenal] 4-hydroxy-2-nonenal affects the localization of NFE2L2 protein 4-hydroxy-2-nonenal affects the localization of and results in increased activity of NFE2L2 protein; [GSTA4 protein mutant form results in decreased glutathionylation of 4-hydroxy-2-nonenal] which results in increased activity of NFE2L2 protein; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 protein]; NFE2L2 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased activity of NFE2L2 protein] 4-hydroxy-2-nonenal results in increased expression of NFE2L2 protein 4-hydroxy-2-nonenal promotes the reaction [NFE2L2 protein binds to GGT1 promoter]; 4-hydroxy-2-nonenal results in increased expression of and results in increased localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of HMOX1 mRNA]
CTD
PMID:16195535 PMID:16322078 PMID:19880816 PMID:24291486 PMID:24423726 PMID:24633890 PMID:29108775 PMID:30849339 More...
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfic
nuclear factor I/C
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NFIC mRNA
CTD
PMID:19191707
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
G
Nfix
nuclear factor I X
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NFIX mRNA
CTD
PMID:12419474
NCBI chr19:23,355,388...23,450,360
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression multiple interactions
ISO EXP
4-hydroxy-2-nonenal results in decreased expression of NFKB1 mRNA 4-hydroxy-2-nonenal results in decreased activity of [NFKB1 protein binds to NFKB1 protein]; 4-hydroxy-2-nonenal results in decreased activity of [RELA protein binds to NFKB1 protein]
CTD
PMID:11146106 PMID:12419474 PMID:19191707
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions increases expression
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] 4-hydroxy-2-nonenal results in increased expression of NFKBIA mRNA
CTD
PMID:19191707 PMID:19627980
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NFKBIE mRNA
CTD
PMID:19191707
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfkbiz
NFKB inhibitor zeta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NFKBIZ mRNA
CTD
PMID:19191707
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nfrkb
nuclear factor related to kappa B binding protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NFRKB mRNA
CTD
PMID:12419474
NCBI chr 8:29,831,802...29,863,360
Ensembl chr 8:29,831,812...29,863,359
G
Nfx1
nuclear transcription factor, X-box binding 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NFX1 mRNA
CTD
PMID:12419474
NCBI chr 5:56,104,945...56,162,912
Ensembl chr 5:56,105,234...56,162,912
G
Nkiras1
NFKB inhibitor interacting Ras-like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NKIRAS1 mRNA
CTD
PMID:19191707
NCBI chr15:7,493,531...7,503,758
Ensembl chr15:7,493,531...7,503,854
G
Nlrc4
NLR family, CARD domain containing 4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NLRC4 mRNA
CTD
PMID:19191707
NCBI chr 6:20,991,785...21,018,254
Ensembl chr 6:20,995,266...21,018,248
G
Nlrp10
NLR family, pyrin domain containing 10
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NLRP10 mRNA
CTD
PMID:19191707
NCBI chr 1:162,922,806...162,930,363
Ensembl chr 1:162,922,806...162,930,363
G
Nlrp3
NLR family, pyrin domain containing 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NLRP3 mRNA
CTD
PMID:19191707
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Nmb
neuromedin B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NMB mRNA
CTD
PMID:12419474
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NME2 mRNA
CTD
PMID:12419474
NCBI chr10:78,898,097...78,903,514
Ensembl chr10:78,897,770...78,903,538
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NOS2 protein
CTD
PMID:20940037
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NOTCH1 mRNA
CTD
PMID:19191707
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NQO1 mRNA 4-hydroxy-2-nonenal results in increased expression of NQO1 mRNA; 4-hydroxy-2-nonenal results in increased expression of NQO1 protein
CTD
PMID:24423726 PMID:29108775 PMID:30849339
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NR1D1 mRNA
CTD
PMID:19191707
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NR1D2 mRNA
CTD
PMID:19191707
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NR1I3 mRNA
CTD
PMID:12419474
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NR2F6 mRNA
CTD
PMID:12419474
NCBI chr16:18,046,012...18,053,914
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NR3C1 mRNA
CTD
PMID:19191707
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NR4A1 mRNA
CTD
PMID:19191707
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Nrp1
neuropilin 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NRP1 mRNA
CTD
PMID:19191707
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nsl1
NSL1 component of MIS12 kinetochore complex
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NSL1 mRNA
CTD
PMID:19191707
NCBI chr13:102,649,050...102,674,059
Ensembl chr13:102,649,058...102,674,054
G
Nuf2
NUF2 component of NDC80 kinetochore complex
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NUF2 mRNA
CTD
PMID:19191707
NCBI chr13:81,693,675...81,722,765
Ensembl chr13:81,693,598...81,722,766
G
Nufip1
nuclear FMR1 interacting protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NUFIP1 mRNA
CTD
PMID:19191707
NCBI chr15:51,429,518...51,460,308
Ensembl chr15:51,429,549...51,460,310
G
Nup210
nucleoporin 210
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NUP210 mRNA
CTD
PMID:19191707
NCBI chr 4:123,511,558...123,609,874
Ensembl chr 4:123,511,559...123,609,874
G
Nup85
nucleoporin 85
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of NUP85 mRNA
CTD
PMID:19191707
NCBI chr10:100,806,482...100,825,029
Ensembl chr10:100,806,437...100,825,043
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of NUSAP1 mRNA
CTD
PMID:19191707
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
G
Oas3
2'-5'-oligoadenylate synthetase 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of OAS3 mRNA
CTD
PMID:19191707
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Olr1271
olfactory receptor 1271
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of OR8D1 mRNA; 4-hydroxy-2-nonenal results in increased expression of OR8D1B mRNA
CTD
PMID:19191707
NCBI chr 8:39,127,409...39,131,889
Ensembl chr 8:39,127,352...39,131,900
G
Osm
oncostatin M
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of OSM mRNA
CTD
PMID:19191707
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
G
Otub1
OTU deubiquitinase, ubiquitin aldehyde binding 1
multiple interactions
ISO
[[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal
CTD
PMID:35234341
NCBI chr 1:204,387,215...204,395,495
Ensembl chr 1:204,387,215...204,395,483
G
P2rx5
purinergic receptor P2X 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of P2RX5 mRNA
CTD
PMID:12419474
NCBI chr10:57,777,737...57,789,426
Ensembl chr10:57,777,819...57,789,423
G
P2ry2
purinergic receptor P2Y2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of P2RY2 mRNA
CTD
PMID:19191707
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
G
P4hb
prolyl 4-hydroxylase subunit beta
affects metabolic processing
EXP
4-hydroxy-2-nonenal affects the metabolism of P4HB protein
CTD
PMID:16097806
NCBI chr10:105,836,972...105,848,583
Ensembl chr10:105,836,982...105,848,500
G
Pa2g4
proliferation-associated 2G4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PA2G4 mRNA
CTD
PMID:19191707
NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
G
Paip1
poly(A) binding protein interacting protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PAIP1 mRNA
CTD
PMID:12419474
NCBI chr 2:51,523,190...51,550,241
Ensembl chr 2:51,522,921...51,550,241
G
Parp1
poly (ADP-ribose) polymerase 1
increases degradation
ISO
4-hydroxy-2-nonenal results in increased degradation of PARP1 protein
CTD
PMID:11488593
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp12
poly (ADP-ribose) polymerase family, member 12
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PARP12 mRNA
CTD
PMID:19191707
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Pbk
PDZ binding kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PBK mRNA
CTD
PMID:19191707
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
G
Pcgf5
polycomb group ring finger 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PCGF5 mRNA
CTD
PMID:19191707
NCBI chr 1:234,063,854...234,180,022
Ensembl chr 1:234,063,892...234,175,315
G
Pcna
proliferating cell nuclear antigen
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PCNA mRNA
CTD
PMID:19191707
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PCSK2 mRNA
CTD
PMID:12419474
NCBI chr 3:130,880,422...131,183,127
Ensembl chr 3:130,880,422...131,183,127
G
Pcyox1
prenylcysteine oxidase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PCYOX1 mRNA
CTD
PMID:19191707
NCBI chr 4:118,832,114...118,842,951
Ensembl chr 4:118,830,638...118,842,951
G
Pdcd4
programmed cell death 4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PDCD4 mRNA
CTD
PMID:19191707
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
G
Pdgfb
platelet derived growth factor subunit B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PDGFB mRNA
CTD
PMID:19191707
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdia3
protein disulfide isomerase family A, member 3
affects binding
ISO
4-hydroxy-2-nonenal analog binds to PDIA3
CTD
PMID:18232660
NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
G
Pdss1
decaprenyl diphosphate synthase subunit 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PDSS1 mRNA
CTD
PMID:19191707
NCBI chr17:85,059,953...85,098,739
Ensembl chr17:85,060,106...85,098,730
G
Pdyn
prodynorphin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PDYN mRNA
CTD
PMID:12419474
NCBI chr 3:116,900,990...116,913,334
Ensembl chr 3:116,900,992...116,913,334
G
Penk
proenkephalin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PENK mRNA
CTD
PMID:19191707
NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
G
Per1
period circadian regulator 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PER1 mRNA
CTD
PMID:19191707
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Pex7
peroxisomal biogenesis factor 7
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PEX7 mRNA
CTD
PMID:19191707
NCBI chr 1:14,582,698...14,646,686
Ensembl chr 1:14,582,699...14,646,748
G
Pgd
phosphogluconate dehydrogenase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PGD mRNA
CTD
PMID:19191707
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pglyrp3
peptidoglycan recognition protein 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PGLYRP3 mRNA
CTD
PMID:19191707
NCBI chr 2:177,479,693...177,490,769
Ensembl chr 2:177,477,407...177,490,736 Ensembl chr 2:177,477,407...177,490,736
G
Pgm2l1
phosphoglucomutase 2-like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PGM2L1 mRNA
CTD
PMID:19191707
NCBI chr 1:154,571,410...154,620,901
Ensembl chr 1:154,571,766...154,620,902
G
Pgs1
phosphatidylglycerophosphate synthase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PGS1 mRNA
CTD
PMID:19191707
NCBI chr10:103,214,635...103,250,254
Ensembl chr10:103,214,646...103,250,254
G
Phb1
prohibitin 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PHB1 mRNA
CTD
PMID:12419474
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Phf11
PHD finger protein 11
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PHF11 mRNA
CTD
PMID:19191707
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
G
Phf21a
PHD finger protein 21A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PHF21A mRNA
CTD
PMID:19191707
NCBI chr 3:78,158,760...78,331,903
Ensembl chr 3:78,194,549...78,331,865
G
Phgdh
phosphoglycerate dehydrogenase
affects binding
ISO
PHGDH protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 2:185,906,962...185,936,054
Ensembl chr 2:185,906,966...185,935,944
G
Phlda1
pleckstrin homology-like domain, family A, member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PHLDA1 mRNA
CTD
PMID:19191707
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PIK3CB mRNA
CTD
PMID:19191707
NCBI chr 8:99,594,600...99,699,772
Ensembl chr 8:99,594,644...99,699,663
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PIK3CD mRNA
CTD
PMID:19191707
NCBI chr 5:160,094,952...160,142,962
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PIK3R2 mRNA
CTD
PMID:12419474
NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,665,457...18,674,065
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PILRA mRNA
CTD
PMID:19191707
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
affects binding increases response to substance
ISO
4-hydroxy-2-nonenal binds to PIN1 protein PIN1 protein results in increased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:23231502
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
G
Pkm
pyruvate kinase M1/2
affects binding multiple interactions
ISO
4-hydroxy-2-nonenal analog binds to PKM protein 4-hydroxy-2-nonenal binds to and results in decreased activity of PKM protein; 4-hydroxy-2-nonenal promotes the reaction [PKM protein binds to PKM protein]
CTD
PMID:27978618
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Pla2g7
phospholipase A2 group VII
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PLA2G7 mRNA
CTD
PMID:19191707
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plagl2
PLAG1 like zinc finger 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PLAGL2 mRNA
CTD
PMID:19191707
NCBI chr 3:141,695,322...141,708,516
Ensembl chr 3:141,695,322...141,708,503
G
Pld2
phospholipase D2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PLD2 mRNA
CTD
PMID:19191707
NCBI chr10:55,256,326...55,274,192
Ensembl chr10:55,256,359...55,272,808
G
Plekhm1
pleckstrin homology and RUN domain containing M1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PLEKHM1 mRNA
CTD
PMID:19191707
NCBI chr10:88,313,837...88,366,182
Ensembl chr10:88,314,651...88,362,412
G
Plekho1
pleckstrin homology domain containing O1
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PLEKHO1 mRNA 4-hydroxy-2-nonenal results in increased expression of PLEKHO1 mRNA
CTD
PMID:19191707
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plk1
polo-like kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PLK1 mRNA
CTD
PMID:19191707
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
G
Plk2
polo-like kinase 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PLK2 mRNA
CTD
PMID:19191707
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Polb
DNA polymerase beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of POLB mRNA
CTD
PMID:12419474
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of POLD1 mRNA
CTD
PMID:12419474
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Pole
DNA polymerase epsilon, catalytic subunit
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of POLE mRNA
CTD
PMID:19191707
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939
G
Polh
DNA polymerase eta
multiple interactions affects response to substance
ISO
POLH protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] POLH protein affects the susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:22331492
NCBI chr 9:14,778,355...14,813,210
Ensembl chr 9:14,777,888...14,812,723
G
Polk
DNA polymerase kappa
multiple interactions
ISO
POLK protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]
CTD
PMID:22331492
NCBI chr 2:27,822,228...27,882,331
Ensembl chr 2:27,822,679...27,882,313
G
Poll
DNA polymerase lambda
affects response to substance multiple interactions
ISO
POLL protein affects the susceptibility to 4-hydroxy-2-nonenal POLL protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein]
CTD
PMID:22331492
NCBI chr 1:244,400,202...244,408,762
Ensembl chr 1:244,400,204...244,408,662
G
Polq
DNA polymerase theta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of POLQ mRNA
CTD
PMID:19191707
NCBI chr11:63,673,796...63,775,905
Ensembl chr11:63,673,816...63,775,878
G
Pon1
paraoxonase 1
multiple interactions decreases activity
ISO
4-hydroxy-2-nonenal inhibits the reaction [PON1 protein results in increased hydrolysis of Paraoxon]; 4-hydroxy-2-nonenal inhibits the reaction [PON1 protein results in increased hydrolysis of phenylacetic acid] 4-hydroxy-2-nonenal results in decreased activity of PON1 protein
CTD
PMID:15375178
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Pou2f2
POU class 2 homeobox 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of POU2F2 mRNA
CTD
PMID:19191707
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PPARG protein
CTD
PMID:27417252
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppid
peptidylprolyl isomerase D
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PPID mRNA
CTD
PMID:19191707
NCBI chr 2:164,727,803...164,740,168
Ensembl chr 2:164,727,779...164,740,221
G
Ppil1
peptidylprolyl isomerase like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PPIL1 mRNA
CTD
PMID:19191707
NCBI chr20:7,302,292...7,322,349
Ensembl chr20:7,302,621...7,322,354
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PPP1CA mRNA
CTD
PMID:12419474
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of PPP1R15A mRNA]
CTD
PMID:24291486
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r15b
protein phosphatase 1, regulatory subunit 15B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PPP1R15B mRNA
CTD
PMID:19191707
NCBI chr13:44,577,840...44,585,737
Ensembl chr13:44,577,932...44,585,737
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PPP3CA mRNA
CTD
PMID:12419474
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
G
Prdm1
PR/SET domain 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PRDM1 mRNA
CTD
PMID:12419474
NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
G
Prdx1
peroxiredoxin 1
affects binding increases expression
ISO
4-hydroxy-2-nonenal analog binds to PRDX1 4-hydroxy-2-nonenal results in increased expression of PRDX1 mRNA
CTD
PMID:18232660 PMID:19191707
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PRKDC mRNA
CTD
PMID:12419474
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
G
Procr
protein C receptor
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PROCR mRNA
CTD
PMID:19191707
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PSMB10 mRNA
CTD
PMID:19191707
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmc3ip
PSMC3 interacting protein
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PSMC3IP mRNA
CTD
PMID:19191707
NCBI chr10:86,024,281...86,027,928
Ensembl chr10:86,023,950...86,027,423
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PSMD12 mRNA
CTD
PMID:19191707
NCBI chr10:92,438,223...92,457,323
Ensembl chr10:92,438,298...92,457,287
G
Ptger4
prostaglandin E receptor 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PTGER4 mRNA
CTD
PMID:19191707
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptges
prostaglandin E synthase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PTGES mRNA
CTD
PMID:19191707
NCBI chr 3:14,177,892...14,189,236
G
Ptgr1
prostaglandin reductase 1
multiple interactions decreases response to substance
EXP
[PTGR1 protein co-treated with NADP] affects the reduction of 4-hydroxy-2-nonenal PTGR1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:11524419
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PTK2 mRNA
CTD
PMID:12419474
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PTPN1 mRNA
CTD
PMID:12419474
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
G
Ptpra
protein tyrosine phosphatase, receptor type, A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of PTPRA mRNA
CTD
PMID:19191707
NCBI chr 3:117,650,146...117,759,744
Ensembl chr 3:117,650,183...117,759,728
G
Pxk
PX domain containing serine/threonine kinase like
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of PXK mRNA
CTD
PMID:19191707
NCBI chr15:16,759,857...16,828,452
Ensembl chr15:16,759,862...16,828,444
G
Rab11a
RAB11a, member RAS oncogene family
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RAB11A mRNA
CTD
PMID:19191707
NCBI chr 8:65,223,698...65,246,461
Ensembl chr 8:65,222,949...65,246,525
G
Rabgef1
RAB guanine nucleotide exchange factor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RABGEF1 mRNA
CTD
PMID:19191707
NCBI chr12:26,459,190...26,503,790
Ensembl chr12:26,460,175...26,503,744
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RAD23A mRNA
CTD
PMID:19191707
NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
G
Rad51
RAD51 recombinase
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RAD51 mRNA 4-hydroxy-2-nonenal results in increased expression of RAD51 mRNA
CTD
PMID:19191707
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
G
Rad54l
RAD54 like
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RAD54L mRNA
CTD
PMID:19191707
NCBI chr 5:129,575,431...129,605,100
Ensembl chr 5:129,575,378...129,605,070
G
Raet1e
retinoic acid early transcript 1E
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RAET1E mRNA
CTD
PMID:19191707
NCBI chr 1:1,662,665...1,664,609
Ensembl chr 1:1,807,644...1,812,755
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RAF1 mRNA
CTD
PMID:19191707
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
G
Ralbp1
ralA binding protein 1
decreases response to substance
ISO
RALBP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:15950949
NCBI chr 9:105,456,425...105,493,235
Ensembl chr 9:105,456,425...105,492,707
G
Ralgds
ral guanine nucleotide dissociation stimulator
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RALGDS mRNA
CTD
PMID:12419474
NCBI chr 3:11,839,686...11,880,059
Ensembl chr 3:11,839,416...11,880,059
G
Ralgps1
Ral GEF with PH domain and SH3 binding motif 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RALGPS1 mRNA
CTD
PMID:19191707
NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972
G
Rara
retinoic acid receptor, alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RARA mRNA
CTD
PMID:19191707
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rarb
retinoic acid receptor, beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RARB mRNA
CTD
PMID:12419474
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
G
Rasgef1b
RasGEF domain family, member 1B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RASGEF1B mRNA
CTD
PMID:19191707
NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
G
Rasgrp3
RAS guanyl releasing protein 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RASGRP3 mRNA
CTD
PMID:19191707
NCBI chr 6:19,895,361...19,993,945
Ensembl chr 6:19,895,390...19,958,578
G
Rassf2
Ras association domain family member 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RASSF2 mRNA
CTD
PMID:19191707
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
G
Rassf8
Ras association domain family member 8
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RASSF8 mRNA
CTD
PMID:19191707
NCBI chr 4:178,716,110...178,798,042
Ensembl chr 4:178,719,992...178,796,690
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation multiple interactions
ISO
4-hydroxy-2-nonenal results in decreased phosphorylation of RB1 protein [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of RB1 protein modified form
CTD
PMID:15607904 PMID:33007382
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbl1
RB transcriptional corepressor like 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA
CTD
PMID:19191707
NCBI chr 3:145,806,160...145,869,434
Ensembl chr 3:145,807,095...145,869,330
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RBL2 mRNA
CTD
PMID:12419474
NCBI chr19:15,876,852...15,923,632
Ensembl chr19:15,876,853...15,923,572
G
Rel
REL proto-oncogene, NF-kB subunit
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of REL mRNA
CTD
PMID:12419474
NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
4-hydroxy-2-nonenal results in decreased activity of [RELA protein binds to NFKB1 protein]
CTD
PMID:11146106
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rev1
REV1, DNA directed polymerase
multiple interactions affects response to substance
ISO
REV1 protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] REV1 protein affects the susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:22331492
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
G
Rev3l
REV3 like, DNA directed polymerase zeta catalytic subunit
multiple interactions affects response to substance
ISO
REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AX protein] REV3L protein affects the susceptibility to 4-hydroxy-2-nonenal
CTD
PMID:22331492
NCBI chr20:43,131,841...43,290,102
Ensembl chr20:43,132,363...43,290,099
G
Rffl
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RFFL mRNA
CTD
PMID:19191707
NCBI chr10:67,740,711...67,803,669
Ensembl chr10:67,740,712...67,824,434
G
Rgs1
regulator of G-protein signaling 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RGS1 mRNA
CTD
PMID:19191707
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
G
Rig1
RNA sensor RIG-1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RIGI mRNA
CTD
PMID:19191707
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Riok3
RIO kinase 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RIOK3 mRNA
CTD
PMID:19191707
NCBI chr18:3,327,776...3,353,350
Ensembl chr18:3,327,776...3,353,343
G
Rit1
Ras-like without CAAX 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RIT1 mRNA
CTD
PMID:19191707
NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:174,180,848...174,195,455
G
Rnd1
Rho family GTPase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RND1 mRNA
CTD
PMID:19191707
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf128
ring finger protein 128
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RNF128 mRNA
CTD
PMID:19191707
NCBI chr X:103,183,643...103,298,431
Ensembl chr X:103,183,831...103,298,423
G
Rnf167
ring finger protein 167
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RNF167 mRNA
CTD
PMID:19191707
NCBI chr10:55,360,603...55,364,927
Ensembl chr10:55,360,543...55,364,927
G
Rnf19b
ring finger protein 19B
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RNF19B mRNA
CTD
PMID:19191707
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rpp38
ribonuclease P/MRP subunit p38
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RPP38 mRNA
CTD
PMID:19191707
NCBI chr17:74,914,066...74,917,742
Ensembl chr17:74,908,932...74,927,431
G
Rps6ka2
ribosomal protein S6 kinase A2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RPS6KA2 mRNA
CTD
PMID:12419474
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6kb1
ribosomal protein S6 kinase B1
increases phosphorylation
EXP
4-hydroxy-2-nonenal results in increased phosphorylation of RPS6KB1 protein
CTD
PMID:19289642
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Rsad2
radical S-adenosyl methionine domain containing 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RSAD2 mRNA
CTD
PMID:19191707
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of H2-T23 mRNA
CTD
PMID:19191707
NCBI chr20:4,870,939...4,910,183
G
RT1-CE16
RT1 class I, locus CE16
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of H2-Q1 mRNA
CTD
PMID:19191707
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
Rxra
retinoid X receptor alpha
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of RXRA mRNA
CTD
PMID:19191707
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
Rxrb
retinoid X receptor beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of RXRB mRNA
CTD
PMID:12419474
NCBI chr20:4,816,813...4,823,267
Ensembl chr20:4,816,815...4,828,773
G
S1pr2
sphingosine-1-phosphate receptor 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of S1PR2 mRNA
CTD
PMID:19191707
NCBI chr 8:19,503,276...19,514,169
Ensembl chr 8:19,502,627...19,523,574
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
affects binding
ISO
SAMHD1 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SAMSN1 mRNA
CTD
PMID:19191707
NCBI chr11:14,484,523...14,534,900
Ensembl chr11:14,483,893...14,534,900
G
Sass6
SAS-6 centriolar assembly protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SASS6 mRNA
CTD
PMID:19191707
NCBI chr 2:204,546,660...204,578,930
Ensembl chr 2:204,546,660...204,578,927
G
Satb1
SATB homeobox 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SATB1 mRNA
CTD
PMID:12419474
NCBI chr 9:4,677,817...4,773,061
Ensembl chr 9:4,680,920...4,753,251
G
Sbno2
strawberry notch homolog 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SBNO2 mRNA
CTD
PMID:19191707
NCBI chr 7:9,605,572...9,649,529
Ensembl chr 7:9,605,627...9,649,527
G
Scarb1
scavenger receptor class B, member 1
multiple interactions affects binding
ISO
Tobacco Smoke Pollution promotes the reaction [4-hydroxy-2-nonenal binds to SCARB1 protein]
CTD
PMID:22442701
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Selenbp1
selenium binding protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SELENBP1 mRNA
CTD
PMID:12419474
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Serbp1
Serpine1 mRNA binding protein 1
affects binding
ISO
SERBP1 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
G
Serpinb5
serpin family B member 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SERPINB5 mRNA
CTD
PMID:12419474
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
G
Serpinb9
serpin family B member 9
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SERPINB9 mRNA
CTD
PMID:19191707
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpini1
serpin family I member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SERPINI1 mRNA
CTD
PMID:12419474
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sesn2
sestrin 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SESN2 mRNA
CTD
PMID:19191707
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sgk1
serum/glucocorticoid regulated kinase 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SGK1 mRNA
CTD
PMID:19191707
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Sgo1
shugoshin 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SGO1 mRNA
CTD
PMID:19191707
NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,672,123...6,687,805
G
Sgo2
shugoshin 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SGO2 mRNA
CTD
PMID:19191707
NCBI chr 9:59,548,605...59,573,229
Ensembl chr 9:59,548,683...59,573,229
G
Sgpl1
sphingosine-1-phosphate lyase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SGPL1 mRNA
CTD
PMID:19191707
NCBI chr20:29,047,793...29,094,209
Ensembl chr20:29,047,796...29,094,084
G
Shoc2
SHOC2 leucine-rich repeat scaffold protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SHOC2 mRNA
CTD
PMID:12419474
NCBI chr 1:252,958,939...253,048,820
Ensembl chr 1:252,959,723...253,047,337
G
Sirt1
sirtuin 1
multiple interactions
ISO
SIRT1 protein inhibits the reaction [Tobacco Smoke Pollution results in increased abundance of 4-hydroxy-2-nonenal]
CTD
PMID:24633890
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
multiple interactions
ISO
4-hydroxy-2-nonenal binds to and results in decreased activity of SIRT3 protein
CTD
PMID:21449565
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Slc25a27
solute carrier family 25, member 27
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SLC25A27 mRNA
CTD
PMID:20385226
NCBI chr 9:17,306,898...17,333,942
Ensembl chr 9:17,307,023...17,332,731
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
ISO
[APC protein mutant form results in increased expression of SLC7A11 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal [[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal
CTD
PMID:21967605 PMID:35234341
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a2
solute carrier family 7 member 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SLC7A2 mRNA
CTD
PMID:19191707
NCBI chr16:51,417,478...51,470,784
Ensembl chr16:51,417,493...51,470,784
G
Smad1
SMAD family member 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SMAD1 mRNA
CTD
PMID:12419474
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
G
Smc4
structural maintenance of chromosomes 4
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SMC4 mRNA
CTD
PMID:19191707
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Snapc5
small nuclear RNA activating complex, polypeptide 5
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SNAPC5 mRNA
CTD
PMID:19191707
NCBI chr 8:64,677,204...64,680,769
Ensembl chr 8:64,677,205...64,681,964
G
Socs3
suppressor of cytokine signaling 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SOCS3 mRNA
CTD
PMID:19191707
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
affects binding increases abundance multiple interactions decreases abundance increases expression
ISO
4-hydroxy-2-nonenal binds to SOD2 protein SOD2 gene mutant form results in increased abundance of 4-hydroxy-2-nonenal SOD2 protein inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased abundance of 4-hydroxy-2-nonenal] SOD2 protein results in decreased abundance of 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal results in increased expression of SOD2 mRNA
CTD
PMID:11507057 PMID:19191707 PMID:19374891 PMID:23199288
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sp100
SP100 nuclear antigen
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SP100 mRNA
CTD
PMID:19191707
NCBI chr 9:86,310,990...86,377,036
Ensembl chr 9:86,311,032...86,377,034
G
Sp110
SP110 nuclear body protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SP110 mRNA
CTD
PMID:19191707
NCBI chr 9:86,200,503...86,225,355
Ensembl chr 9:86,200,503...86,222,670
G
Sp2
Sp2 transcription factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SP2 mRNA
CTD
PMID:12419474
NCBI chr10:81,940,580...81,970,040
Ensembl chr10:81,940,587...81,970,548
G
Spa17
sperm autoantigenic protein 17
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SPA17 mRNA
CTD
PMID:19191707
NCBI chr 8:37,307,432...37,318,519
Ensembl chr 8:37,307,557...37,318,639
G
Spag5
sperm associated antigen 5
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SPAG5 mRNA
CTD
PMID:19191707
NCBI chr10:63,198,717...63,216,746
Ensembl chr10:63,198,768...63,216,745
G
Spry1
sprouty RTK signaling antagonist 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SPRY1 mRNA
CTD
PMID:19191707
NCBI chr 2:120,557,256...120,561,917
Ensembl chr 2:120,556,706...120,566,189
G
Spry2
sprouty RTK signaling antagonist 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SPRY2 mRNA
CTD
PMID:12419474
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
G
Sqstm1
sequestosome 1
increases expression multiple interactions
ISO
4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA]
CTD
PMID:19191707 PMID:35550146
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SRC mRNA
CTD
PMID:19191707
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srp9
signal recognition particle 9
affects binding
ISO
SRP9 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr13:93,832,580...93,840,720
Ensembl chr13:93,832,580...93,840,720
G
Srpk2
SRSF protein kinase 2
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SRPK2 mRNA
CTD
PMID:19191707
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srxn1
sulfiredoxin 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SRXN1 mRNA
CTD
PMID:19191707 PMID:22003191
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
Ssbp3
single stranded DNA binding protein 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SSBP3 mRNA
CTD
PMID:19191707
NCBI chr 5:121,691,370...121,828,035
Ensembl chr 5:121,691,393...121,827,992
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STAT1 mRNA
CTD
PMID:19191707
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STAT3 mRNA
CTD
PMID:19191707
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STAT5A mRNA
CTD
PMID:19191707
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STAT6 mRNA
CTD
PMID:12419474
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stk11
serine/threonine kinase 11
decreases activity decreases expression multiple interactions affects binding
EXP
4-hydroxy-2-nonenal results in decreased activity of STK11 protein 4-hydroxy-2-nonenal results in decreased expression of STK11 protein; 4-hydroxy-2-nonenal results in decreased expression of STK11 protein modified form resveratrol inhibits the reaction [4-hydroxy-2-nonenal binds to STK11 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased activity of STK11 protein]; resveratrol inhibits the reaction [4-hydroxy-2-nonenal results in decreased expression of STK11 protein modified form]
CTD
PMID:19289642
NCBI chr 7:9,574,553...9,591,315
Ensembl chr 7:9,575,269...9,591,315
G
Stk17b
serine/threonine kinase 17b
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STK17B mRNA
CTD
PMID:19191707
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Stk3
serine/threonine kinase 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of STK3 mRNA
CTD
PMID:19191707
NCBI chr 7:66,053,209...66,323,292
Ensembl chr 7:66,052,345...66,323,233
G
Stmn1
stathmin 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of STMN1 mRNA
CTD
PMID:19191707
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Stradb
STE20 related adaptor beta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of STRADB mRNA
CTD
PMID:19191707
NCBI chr 9:60,414,182...60,433,084
Ensembl chr 9:60,414,182...60,433,084
G
Suclg1
succinate-CoA ligase GDP/ADP-forming subunit alpha
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SUCLG1 mRNA
CTD
PMID:19191707
NCBI chr 4:105,308,236...105,337,595
Ensembl chr 4:105,308,039...105,337,600
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SUMO3 mRNA
CTD
PMID:19191707
NCBI chr20:11,010,140...11,020,850
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
G
Suv39h1
SUV39H1 histone lysine methyltransferase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SUV39H1 mRNA
CTD
PMID:19191707
NCBI chr X:14,421,028...14,433,993
Ensembl chr X:14,421,109...14,433,982
G
Suv39h1-ps1
SUV39H1 histone lysine methyltransferase, pseudogene 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of SUV39H1 mRNA
CTD
PMID:19191707
NCBI chr X:141,792,589...141,795,257
G
Syp
synaptophysin
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of SYP mRNA
CTD
PMID:12419474
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
G
Tac1
tachykinin, precursor 1
increases secretion
EXP
4-hydroxy-2-nonenal results in increased secretion of TAC1 protein
CTD
PMID:17684094
NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:35,679,704...35,687,178
G
Tacc3
transforming, acidic coiled-coil containing protein 3
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TACC3 mRNA 4-hydroxy-2-nonenal results in increased expression of TACC3 mRNA
CTD
PMID:19191707
NCBI chr14:77,051,209...77,065,343
Ensembl chr14:77,051,215...77,065,219
G
Tada3
transcriptional adaptor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TADA3 mRNA
CTD
PMID:12419474
NCBI chr 4:146,510,213...146,521,975
Ensembl chr 4:146,510,246...146,521,590
G
Tank
TRAF family member-associated NFKB activator
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TANK mRNA
CTD
PMID:12419474
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
G
Tbc1d12
TBC1 domain family, member 12
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TBC1D12 mRNA
CTD
PMID:19191707
NCBI chr 1:236,603,597...236,685,859
Ensembl chr 1:236,603,607...236,685,859
G
Tbc1d31
TBC1 domain family, member 31
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TBC1D31 mRNA
CTD
PMID:19191707
NCBI chr 7:89,427,354...89,506,894
Ensembl chr 7:89,426,780...89,506,894
G
Tbc1d8b
TBC1 domain family member 8B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TBC1D8B mRNA
CTD
PMID:19191707
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbl1xr1
TBL1X/Y related 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TBL1XR1 mRNA
CTD
PMID:19191707
NCBI chr 2:104,788,950...104,929,055
Ensembl chr 2:104,801,721...104,929,055
G
Tcf3
transcription factor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TCF3 mRNA
CTD
PMID:12419474
NCBI chr 7:9,280,571...9,302,315
Ensembl chr 7:9,280,571...9,302,314
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TERF1 mRNA
CTD
PMID:12419474
NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340
G
Tfdp2
transcription factor Dp-2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TFDP2 mRNA
CTD
PMID:12419474
NCBI chr 8:96,760,459...96,901,466
Ensembl chr 8:96,760,504...96,896,682
G
Tfeb
transcription factor EB
multiple interactions affects response to substance affects localization
ISO
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [4-hydroxy-2-nonenal affects the localization of TFEB protein]; 4-hydroxy-2-nonenal results in decreased phosphorylation of and affects the localization of TFEB protein; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal affects the localization of TFEB protein]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of CTSD mRNA]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of LAMP1 protein]; TFEB protein affects the reaction [4-hydroxy-2-nonenal results in increased expression of SQSTM1 mRNA] TFEB protein affects the susceptibility to 4-hydroxy-2-nonenal 4-hydroxy-2-nonenal affects the localization of TFEB protein; 4-hydroxy-2-nonenal affects the localization of TFEB protein mutant form
CTD
PMID:35550146
NCBI chr 9:13,198,890...13,254,726
Ensembl chr 9:13,198,891...13,254,714
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TGFB1 mRNA
CTD
PMID:19191707
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TGFBR1 mRNA
CTD
PMID:19191707
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Thra
thyroid hormone receptor alpha
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of THRA mRNA
CTD
PMID:19191707
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression decreases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TIMP1 mRNA 4-hydroxy-2-nonenal results in decreased expression of TIMP1 mRNA
CTD
PMID:14672615 PMID:19191707
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TIPARP mRNA
CTD
PMID:19191707
NCBI chr 2:149,753,682...149,780,327
Ensembl chr 2:149,753,682...149,780,327
G
Tjp1
tight junction protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TJP1 mRNA
CTD
PMID:12419474
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tlr4
toll-like receptor 4
multiple interactions decreases activity
ISO
4-hydroxy-2-nonenal inhibits the reaction [TLR4 protein binds to TLR4 protein] 4-hydroxy-2-nonenal results in decreased activity of TLR4 protein 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]]; Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]]
CTD
PMID:19627980
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO
4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of TNF protein 4-hydroxy-2-nonenal results in increased expression of TNF mRNA
CTD
PMID:19191707 PMID:19627980 PMID:33007382
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TNFAIP2 mRNA
CTD
PMID:12419474
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tnfaip3
TNF alpha induced protein 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TNFAIP3 mRNA
CTD
PMID:19191707
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
Tnfaip8
TNF alpha induced protein 8
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TNFAIP8 mRNA 4-hydroxy-2-nonenal results in increased expression of TNFAIP8 mRNA
CTD
PMID:19191707
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TNFRSF10B mRNA
CTD
PMID:19191707
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TNFRSF1A mRNA
CTD
PMID:12419474
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Top1
DNA topoisomerase I
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TOP1 mRNA
CTD
PMID:12419474
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
G
Top2a
DNA topoisomerase II alpha
decreases expression increases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TOP2A mRNA 4-hydroxy-2-nonenal results in increased expression of TOP2A mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
G
Tp53
tumor protein p53
increases expression increases mutagenesis affects abundance
ISO
4-hydroxy-2-nonenal results in increased expression of TP53 mRNA; 4-hydroxy-2-nonenal results in increased expression of TP53 protein 4-hydroxy-2-nonenal results in increased mutagenesis of TP53 gene TRP53 protein affects the abundance of 4-hydroxy-2-nonenal
CTD
PMID:11050162 PMID:15607904 PMID:22229939
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
multiple interactions
ISO
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] affects the expression of TP53BP1 protein
CTD
PMID:34503147
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
G
Tp53inp1
tumor protein p53 inducible nuclear protein 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TRP53INP1 mRNA
CTD
PMID:19191707
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
G
Tp63
tumor protein p63
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TP63 protein
CTD
PMID:15607904
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
G
Tp73
tumor protein p73
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TP73 protein
CTD
PMID:15607904
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
G
Tpi1
triosephosphate isomerase 1
affects binding
ISO
4-hydroxy-2-nonenal binds to TPI1 protein
CTD
PMID:19374891
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
G
Traf3
Tnf receptor-associated factor 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TRAF3 mRNA
CTD
PMID:19191707
NCBI chr 6:130,199,696...130,307,168
Ensembl chr 6:130,206,484...130,305,481
G
Traf3ip2
Traf3 interacting protein 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TRAF3IP2 mRNA
CTD
PMID:19191707
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
G
Trib3
tribbles pseudokinase 3
increases expression multiple interactions
EXP
4-hydroxy-2-nonenal results in increased expression of TRIB3 mRNA 4-phenylbutylamine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of TRIB3 mRNA]; Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of TRIB3 mRNA]
CTD
PMID:24291486
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Trim24
tripartite motif-containing 24
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TRIM24 mRNA
CTD
PMID:12419474
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Trip13
thyroid hormone receptor interactor 13
increases expression decreases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TRIP13 mRNA 4-hydroxy-2-nonenal results in decreased expression of TRIP13 mRNA
CTD
PMID:19191707
NCBI chr 1:29,357,093...29,402,078
Ensembl chr 1:29,357,130...29,402,074
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
multiple interactions increases activity
ISO EXP
Ruthenium Red inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]; TRPA1 gene mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein] 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide inhibits the reaction [4-hydroxy-2-nonenal results in increased activity of TRPA1 protein]
CTD
PMID:17684094 PMID:21689654
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TRPV4 mRNA
CTD
PMID:19191707
NCBI chr12:41,938,533...41,977,517
Ensembl chr12:41,938,560...41,977,517
G
Tsc1
TSC complex subunit 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSC1 mRNA
CTD
PMID:19191707
NCBI chr 3:11,969,547...12,018,591
Ensembl chr 3:11,979,729...12,015,674
G
Tsc2
TSC complex subunit 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSC2 mRNA
CTD
PMID:12419474
NCBI chr10:13,621,135...13,655,773
Ensembl chr10:13,621,136...13,655,951
G
Tsc22d3
TSC22 domain family, member 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSC22D3 mRNA
CTD
PMID:19191707
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tsg101
tumor susceptibility 101
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSG101 mRNA
CTD
PMID:12419474
NCBI chr 1:97,412,689...97,442,589
Ensembl chr 1:97,410,848...97,442,554
G
Tspan31
tetraspanin 31
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSPAN31 mRNA
CTD
PMID:12419474
NCBI chr 7:62,889,552...62,892,428
Ensembl chr 7:62,889,552...62,898,388
G
Tspyl2
TSPY-like 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TSPYL2 mRNA
CTD
PMID:19191707
NCBI chr X:21,439,478...21,445,208
Ensembl chr X:21,439,478...21,445,089
G
Tuba1b
tubulin, alpha 1B
affects binding
ISO
TUBA1B protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba4a
tubulin, alpha 4A
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TUBA4A mRNA
CTD
PMID:19191707
NCBI chr 9:76,709,617...76,714,327
Ensembl chr 9:76,709,614...76,713,918
G
Txn1
thioredoxin 1
decreases activity affects metabolic processing
ISO
4-hydroxy-2-nonenal results in decreased activity of TXN protein 4-hydroxy-2-nonenal affects the metabolism of TXN protein
CTD
PMID:17982132
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txnrd1
thioredoxin reductase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of TXNRD1 mRNA
CTD
PMID:19191707
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
G
Tyr
tyrosinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of TYR mRNA
CTD
PMID:23489423
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
G
Uba1
ubiquitin-like modifier activating enzyme 1
multiple interactions
ISO
4-hydroxy-2-nonenal results in increased activity of and results in increased ubiquitination of UBA1 protein
CTD
PMID:25714994
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
G
Ube2a
ubiquitin-conjugating enzyme E2A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of UBE2A mRNA
CTD
PMID:12419474
NCBI chr X:116,114,339...116,125,076
Ensembl chr X:116,113,875...116,125,070
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of UBE2C mRNA
CTD
PMID:19191707
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
G
Ube2d3
ubiquitin-conjugating enzyme E2D 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of UBE2D3 mRNA
CTD
PMID:19191707
NCBI chr 2:223,868,397...223,899,606
Ensembl chr 2:223,868,730...223,898,081
G
Ube2i
ubiquitin-conjugating enzyme E2I
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of UBE2I mRNA
CTD
PMID:19191707
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of UBE2L6 mRNA
CTD
PMID:19191707
NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048
G
Ube2t
ubiquitin-conjugating enzyme E2T
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of UBE2T mRNA
CTD
PMID:19191707
NCBI chr13:46,403,352...46,413,854
Ensembl chr13:46,403,375...46,414,835
G
Ube4b
ubiquitination factor E4B
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of UBE4B mRNA
CTD
PMID:19191707
NCBI chr 5:159,766,829...159,870,509
Ensembl chr 5:159,766,829...159,870,509
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of UCHL1 mRNA
CTD
PMID:19191707
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Uhrf1
ubiquitin-like with PHD and ring finger domains 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of UHRF1 mRNA
CTD
PMID:19191707
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
G
Ulk1
unc-51 like autophagy activating kinase 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ULK1 mRNA
CTD
PMID:19191707
NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966
G
Usf2
upstream transcription factor 2, c-fos interacting
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of USF2 mRNA
CTD
PMID:19191707
NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:86,174,703...86,185,617
G
Usp18
ubiquitin specific peptidase 18
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of USP18 mRNA
CTD
PMID:19191707
NCBI chr 4:154,471,634...154,499,154
Ensembl chr 4:154,471,592...154,499,144
G
Usp37
ubiquitin specific peptidase 37
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of USP37 mRNA
CTD
PMID:19191707
NCBI chr 9:76,018,863...76,118,732
Ensembl chr 9:76,018,991...76,084,044
G
Uvrag
UV radiation resistance associated
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of UVRAG mRNA
CTD
PMID:19191707
NCBI chr 1:153,185,356...153,442,200
Ensembl chr 1:153,185,395...153,442,136
G
Vdac2
voltage-dependent anion channel 2
affects binding
ISO
VDAC2 protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of VEGFA mRNA
CTD
PMID:19191707
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
affects binding
ISO
VIM protein binds to 4-hydroxy-2-nonenal
CTD
PMID:20043646
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Wnt6
Wnt family member 6
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of WNT6 mRNA
CTD
PMID:19191707
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
G
Wsb2
WD repeat and SOCS box-containing 2
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of WSB2 mRNA
CTD
PMID:19191707
NCBI chr12:39,217,645...39,238,634
Ensembl chr12:39,217,648...39,238,640
G
Xaf1
XIAP associated factor 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of XAF1 mRNA
CTD
PMID:19191707
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Xbp1
X-box binding protein 1
increases splicing
EXP
4-hydroxy-2-nonenal results in increased splicing of XBP1 mRNA
CTD
PMID:24291486
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Xdh
xanthine dehydrogenase
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of XDH mRNA
CTD
PMID:19191707
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xpc
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of XPC mRNA
CTD
PMID:12419474
NCBI chr 4:123,993,670...124,020,922
Ensembl chr 4:123,993,666...124,021,010
G
Ybx3
Y box binding protein 3
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of YBX3 mRNA
CTD
PMID:12419474
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
G
Yes1
YES proto-oncogene 1, Src family tyrosine kinase
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of YES1 mRNA
CTD
PMID:12419474
NCBI chr 9:113,200,256...113,275,942
Ensembl chr 9:113,200,256...113,299,837
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of YWHAH mRNA
CTD
PMID:12419474
NCBI chr14:77,696,332...77,705,715
Ensembl chr14:77,696,333...77,705,741
G
Zbp1
Z-DNA binding protein 1
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ZBP1 mRNA
CTD
PMID:19191707
NCBI chr 3:161,993,351...162,009,297
Ensembl chr 3:161,993,351...162,003,870
G
Zbtb20
zinc finger and BTB domain containing 20
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ZBTB20 mRNA
CTD
PMID:19191707
NCBI chr11:57,052,129...57,791,214
Ensembl chr11:57,072,880...57,510,210
G
Zbtb7c
zinc finger and BTB domain containing 7C
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ZBTB7C mRNA
CTD
PMID:19191707
NCBI chr18:69,441,616...69,765,744
Ensembl chr18:69,441,616...69,765,297
G
Zdhhc18
zinc finger DHHC-type palmitoyltransferase 18
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ZDHHC18 mRNA
CTD
PMID:19191707
NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993
G
Zfp36
zinc finger protein 36
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ZFP36 mRNA
CTD
PMID:12419474 PMID:19191707
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp367
zinc finger protein 367
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ZFP367 mRNA
CTD
PMID:19191707
NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287
G
Zmat3
zinc finger, matrin type 3
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ZMAT3 mRNA
CTD
PMID:19191707
NCBI chr 2:115,106,046...115,136,888
Ensembl chr 2:115,106,966...115,136,863
G
Zscan29-ps1
zinc finger and SCAN domain containing 29, pseudogene 1
increases expression
ISO
4-hydroxy-2-nonenal results in increased expression of ZSCAN29 mRNA
CTD
PMID:19191707
NCBI chr 3:108,136,468...108,140,431
G
Zwilch
zwilch kinetochore protein
decreases expression
ISO
4-hydroxy-2-nonenal results in decreased expression of ZWILCH mRNA
CTD
PMID:19191707
NCBI chr 8:64,638,401...64,670,911
Ensembl chr 8:64,637,672...64,675,916
G
Gsta4
glutathione S-transferase alpha 4
affects binding
EXP
(E)-4-hydroxynon-2-enal binds to Gsta4 protein
RGD
PMID:11018474
RGD:1641942
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
G
Gstp1
glutathione S-transferase pi 1
affects binding
EXP
(E)-4-hydroxynon-2-enal binds to Gstp1 protein
RGD
PMID:11018474
RGD:1641942
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all